Rank,Term,P-value,Z-score,Combined Score,Genes,Adjusted P-value,Gene_set,AD_genes,T2D_genes,Shared_genes,N_AD,N_T2D,N_Shared
1,Alzheimer's Disease,9.574182241674643e-13,41.118721461187214,1137.941540767428,ATP8B4;GRN;APH1B;SHARPIN;IDUA;PLCG2;TREM2;APOE;PICALM;JAZF1,8.051887265248375e-10,GWAS_Catalog_2023,ATP8B4;GRN;APH1B;SHARPIN;IDUA;PLCG2;TREM2;APOE;PICALM;JAZF1,JAZF1,JAZF1,10,1,1
3,Hepatitis B,6.449301462783392e-10,682.1880341880342,14436.380706597645,BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQB1,3.031171687508194e-08,Jensen_DISEASES,BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQB1,BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQB1,BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQB1,4,4,4
1,Lymphoma,2.768257519598744e-10,1023.3333333333334,22521.14429542145,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB1,3.031171687508194e-08,Jensen_DISEASES,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB1,4,4,4
2,Systemic lupus erythematosus,4.676579157361417e-10,50.86513157894737,1092.750069267846,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,3.031171687508194e-08,Jensen_DISEASES,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,7,7,7
4,Type 1 diabetes mellitus,1.4557087603827975e-09,30.18209523809524,614.138420588885,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,5.131373380349361e-08,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,8,8,8
5,Alopecia areata,2.0580390182095984e-09,64.56324324324325,1291.3625000115092,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,5.803670031351067e-08,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,6,6
2,Type 2 Diabetes,3.1745833832778926e-10,11.369909322303531,248.6675861562995,CDKN2B;GIPR;ZC3H4;BTNL2;JADE2;CCND2;MTNR1B;KCNQ1;IGF2BP3;IGF2BP2;APOE;HLA-DQA2;HLA-DQB1;NEUROG3;JAZF1,1.334912312668354e-07,GWAS_Catalog_2023,GIPR;ZC3H4;BTNL2;APOE;HLA-DQA2;HLA-DQB1;JAZF1,CDKN2B;GIPR;ZC3H4;BTNL2;JADE2;CCND2;MTNR1B;KCNQ1;IGF2BP3;IGF2BP2;HLA-DQA2;HLA-DQB1;NEUROG3;JAZF1,GIPR;ZC3H4;BTNL2;HLA-DQA2;HLA-DQB1;JAZF1,7,14,6
6,Systemic scleroderma,5.887671657247697e-09,100.86538461538461,1911.4399113151069,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DQB1,1.3836028394532087e-07,Jensen_DISEASES,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DQB1,HLA-DRA;HLA-DQA2;HLA-DQA1;HLA-DQB2;HLA-DQB1,5,5,5
3,Diabetes (Standard GWA),1.1808307983278416e-09,145.75292397660817,2996.2497930861537,KCNQ1;IGF2BP2;HLA-DQA2;EML2;JAZF1,3.310262337979049e-07,GWAS_Catalog_2023,HLA-DQA2;EML2;JAZF1,KCNQ1;IGF2BP2;HLA-DQA2;EML2;JAZF1,HLA-DQA2;EML2;JAZF1,3,5,3
7,Multiple sclerosis,1.8966468269239348e-08,21.390385917400135,380.3337513478358,HLA-DRA;BTNL2;LRRC16A;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,3.8203886085182116e-07,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;LRRC16A;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,8,7
1,"Diabetes Mellitus, Non-Insulin-Dependent",3.4116998000906893e-10,8.766283524904214,191.0930612197509,CDKN1C;CDKN2B;GRN;GIPR;JADE2;CCND2;MTNR1B;KCNQ1;HLA-DRA;IGF2BP2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;APPL1;JAZF1,7.444328963797884e-07,DisGeNET,GRN;GIPR;HLA-DRA;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;APPL1;JAZF1,CDKN1C;CDKN2B;GIPR;JADE2;CCND2;MTNR1B;KCNQ1;HLA-DRA;IGF2BP2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;JAZF1,GIPR;HLA-DRA;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,11,16,8
2,Rosacea,9.255898558405019e-10,154.33436532507739,3210.245840551111,HLA-DRA;BTNL2;HLA-DQA1;HLA-DRB1;HLA-DQB1,1.0098185327219875e-06,DisGeNET,HLA-DRA;BTNL2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA1;HLA-DRB1;HLA-DQB1,5,5,5
8,Hodgkin's lymphoma,7.705543808342472e-07,249.3875,3510.4172562030494,HLA-DRA;BTNL2;HLA-DRB1,1.3581020962203606e-05,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DRB1,HLA-DRA;BTNL2;HLA-DRB1,HLA-DRA;BTNL2;HLA-DRB1,3,3,3
4,Medication Use For T2D (Number Of Purchases),7.886229150139492e-08,56.953661327231124,931.5091760457739,CCND2;MTNR1B;KCNQ1;JADE2;IGF2BP2,1.5874080281218174e-05,GWAS_Catalog_2023,,CCND2;MTNR1B;KCNQ1;JADE2;IGF2BP2,,0,5,0
5,Glucose Levels,9.437622045908545e-08,32.52743652743653,526.1630552954034,CCND2;MTNR1B;ZC3H4;KCNQ1;IGF2BP2;JAZF1,1.5874080281218174e-05,GWAS_Catalog_2023,ZC3H4;JAZF1,CCND2;MTNR1B;ZC3H4;KCNQ1;IGF2BP2;JAZF1,ZC3H4;JAZF1,2,6,2
3,Diabetes,2.7766098690625647e-08,7.996807661612131,139.14005532349947,CDKN1C;CDKN2B;GIPR;MTNR1B;KCNQ1;IGF2BP2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;APPL1;JAZF1,2.0195209114315056e-05,DisGeNET,GIPR;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;APPL1;JAZF1,CDKN1C;CDKN2B;GIPR;MTNR1B;KCNQ1;IGF2BP2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;JAZF1,GIPR;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,9,13,7
9,Asthma,1.5471774043852934e-06,30.051421657592257,402.0603238806459,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQA1;HLA-DQB1,2.423911266870293e-05,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQA1;HLA-DQB1,5,5,5
6,A Body Shape Index,1.7823026010927974e-07,12.90919759424967,200.61137724979872,IDUA;HLA-DRA;BTNL2;IGF2BP2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,2.4981941458650707e-05,GWAS_Catalog_2023,IDUA;HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;IGF2BP2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,8,8,7
10,Liver cirrhosis,2.0090779258666183e-06,166.23333333333332,2180.6213857197426,HLA-DRA;BTNL2;HLA-DRB1,2.8327998754719317e-05,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DRB1,HLA-DRA;BTNL2;HLA-DRB1,HLA-DRA;BTNL2;HLA-DRB1,3,3,3
5,Autoimmune Primary Adrenal Insufficiency,7.886229150139492e-08,56.953661327231124,931.5091760457739,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,3.441550401120875e-05,DisGeNET,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,5,5,5
4,Sleep disturbances,7.479379607873701e-08,33.90384068278805,556.312217320639,MTNR1B;IDUA;HESX1;APOE;HLA-DQB2;HLA-DQB1,3.441550401120875e-05,DisGeNET,IDUA;HESX1;APOE;HLA-DQB2;HLA-DQB1,MTNR1B;HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,5,3,2
11,Rheumatoid arthritis,4.01075466503539e-06,12.612577924459112,156.7305923160954,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,5.141058252454454e-05,Jensen_DISEASES,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,7,7
12,Ulcerative colitis,4.655828643185317e-06,23.74043062200957,291.47054098485273,PLCG2;HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1,5.470598655742747e-05,Jensen_DISEASES,PLCG2;HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1,5,4,4
7,Adult Asthma,4.872260936827863e-07,78.6232741617357,1142.7529316708928,HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,5.853673496960333e-05,GWAS_Catalog_2023,HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,4,4,4
6,Sequoiosis,1.8428963441211934e-07,498.85,7735.545837634853,HLA-DQB2;HLA-DRB1;HLA-DQB1,6.701999704787408e-05,DisGeNET,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,3,3,3
8,Alzheimer's Disease Or Family History Of Alzheimer's Disease,7.238105298586439e-07,35.353840682788054,499.8586262894535,APH1B;TREM2;ALPK2;APOE;PICALM,7.609058195138993e-05,GWAS_Catalog_2023,APH1B;TREM2;ALPK2;APOE;PICALM,,,5,0,0
13,Acquired metabolic disease,7.068076641023089e-06,11.52920443101712,136.7354671207085,MTNR1B;GIPR;ZC3H4;QPCTL;IGF2BP3;IGF2BP2;JAZF1,7.666144664494274e-05,Jensen_DISEASES,GIPR;ZC3H4;QPCTL;JAZF1,MTNR1B;GIPR;ZC3H4;QPCTL;IGF2BP3;IGF2BP2;JAZF1,GIPR;ZC3H4;QPCTL;JAZF1,4,7,4
7,Diabetes Mellitus,2.689174392290527e-07,6.630002872462658,100.30439468373926,CDKN1C;CDKN2B;GIPR;MTNR1B;KCNQ1;IGF2BP2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;APPL1;JAZF1,7.991221012409406e-05,DisGeNET,GIPR;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;APPL1;JAZF1,CDKN1C;CDKN2B;GIPR;MTNR1B;KCNQ1;IGF2BP2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;JAZF1,GIPR;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,9,13,7
8,Addison Disease,2.929870215365502e-07,42.91630716134599,645.5959106506756,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7.991221012409406e-05,DisGeNET,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,5,5,5
11,"Diabetes Mellitus, Insulin-Dependent",5.156043774620517e-07,7.796473482777474,112.87676673622973,CDKN2B;HLA-DRA;BTNL2;IGF2BP2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3;APPL1,0.00010227715923838154,DisGeNET,HLA-DRA;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;APPL1,CDKN2B;HLA-DRA;BTNL2;IGF2BP2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;NEUROG3,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,9,10,7
9,Hallucinations,4.5435901246271527e-07,39.06127258444619,570.465596822135,GRN;TREM2;APOE;HLA-DRB1;HLA-DQB1,0.00010227715923838154,DisGeNET,GRN;TREM2;APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,5,2,2
10,Chronic iridocyclitis,5.144717054175412e-07,299.28,4333.611893054364,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.00010227715923838154,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
12,Oropharyngeal Neoplasms,7.705543808342472e-07,249.3875,3510.4172562030494,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.00014011247158169396,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
13,Finding of body mass index,1.047857872309331e-06,12.372533543804263,170.3544771163662,MTNR1B;GIPR;ZC3H4;QPCTL;KCNQ1;JADE2;IGF2BP2;JAZF1,0.0001598891440131269,DisGeNET,GIPR;ZC3H4;QPCTL;JAZF1,MTNR1B;GIPR;ZC3H4;QPCTL;KCNQ1;JADE2;IGF2BP2;JAZF1,GIPR;ZC3H4;QPCTL;JAZF1,4,8,4
14,Body mass index,1.047857872309331e-06,12.372533543804263,170.3544771163662,MTNR1B;GIPR;ZC3H4;QPCTL;KCNQ1;JADE2;IGF2BP2;JAZF1,0.0001598891440131269,DisGeNET,GIPR;ZC3H4;QPCTL;JAZF1,MTNR1B;GIPR;ZC3H4;QPCTL;KCNQ1;JADE2;IGF2BP2;JAZF1,GIPR;ZC3H4;QPCTL;JAZF1,4,8,4
15,"Hemoglobinuria, Paroxysmal",1.0991462695677833e-06,213.75,2932.858790587599,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.0001598891440131269,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
16,Narcolepsy,1.187930311259485e-06,15.265825586542718,208.27620768254724,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.00016200399619801227,DisGeNET,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,7,7,7
18,Primary Progressive Nonfluent Aphasia,1.5090658842808145e-06,187.021875,2506.844900242801,GRN;TREM2;APOE,0.0001829323199722632,DisGeNET,GRN;TREM2;APOE,,,3,0,0
17,Antibody measurement (procedure),1.5090658842808145e-06,187.021875,2506.844900242801,HLA-DRA;BTNL2;HLA-DQB1,0.0001829323199722632,DisGeNET,HLA-DRA;BTNL2;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQB1,3,3,3
9,Waist-to-hip Ratio Adjusted For BMI,2.2064145203977102e-06,7.373031496062992,96.02740732377764,KCNQ1;HLA-DRA;BTNL2;IGF2BP2;APOE;IL17RD;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.00020617717907271937,GWAS_Catalog_2023,HLA-DRA;BTNL2;APOE;IL17RD;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,KCNQ1;HLA-DRA;BTNL2;IGF2BP2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,9,9,7
19,Optic Neuritis,1.9530945963267187e-06,53.76248313090419,706.7667359874058,APOE;HLA-DQA1;HLA-DRB1;HLA-DQB1,0.0002242974952202579,DisGeNET,APOE;HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,4,3,3
14,Type 2 diabetes mellitus,2.247947162768211e-05,12.143047990956736,129.9659259399937,MTNR1B;GIPR;KCNQ1;IGF2BP2;HLA-DQA2;JAZF1,0.00022640039282165555,Jensen_DISEASES,GIPR;HLA-DQA2;JAZF1,MTNR1B;GIPR;KCNQ1;IGF2BP2;HLA-DQA2;JAZF1,GIPR;HLA-DQA2;JAZF1,3,6,3
22,Restrictive behavior,2.6078934902344307e-06,149.6025,1923.4345184728184,GRN;TREM2;APOE,0.00024086850389567742,DisGeNET,GRN;TREM2;APOE,,,3,0,0
21,Multiple Sclerosis,2.3935526333646988e-06,6.674411747360972,86.38512142402794,CDKN1C;MTNR1B;HLA-DRA;TREM2;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.00024086850389567742,DisGeNET,HLA-DRA;TREM2;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,CDKN1C;MTNR1B;HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,10,10,8
20,"Multiple Sclerosis, Acute Fulminating",2.3613793112462104e-06,51.06923076923077,661.6664696109867,HLA-DRA;APOE;HLA-DRB1;HLA-DQB1,0.00024086850389567742,DisGeNET,HLA-DRA;APOE;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB1,4,3,3
23,Idiopathic achalasia of esophagus,2.6078934902344307e-06,149.6025,1923.4345184728184,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.00024086850389567742,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
24,Hypersensitivity,2.6493327651220248e-06,17.917560018118678,230.08302073456625,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.00024086850389567742,DisGeNET,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,6,6,6
25,Semantic Dementia,3.314170277334519e-06,135.99545454545455,1715.8958918548644,GRN;TREM2;APOE,0.00028228917235662075,DisGeNET,GRN;TREM2;APOE,,,3,0,0
26,Sleep Disorders,3.3636656651109714e-06,46.417249417249415,584.972420622709,MTNR1B;APOE;HLA-DQB2;HLA-DQB1,0.00028228917235662075,DisGeNET,APOE;HLA-DQB2;HLA-DQB1,MTNR1B;HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,3,3,2
10,Glycated Hemoglobin Levels,3.843547921739476e-06,12.69767441860465,158.32875849462457,TSPAN15;CCND2;MTNR1B;KCNQ1;IGF2BP2;APOE;JAZF1,0.0003232423802182899,GWAS_Catalog_2023,APOE;JAZF1,TSPAN15;CCND2;MTNR1B;KCNQ1;IGF2BP2;JAZF1,JAZF1,2,6,1
12,Type 1 Diabetes,5.505465709096386e-06,22.902816251154203,277.34781869162896,KCNQ1;HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,0.00037025315631144796,GWAS_Catalog_2023,HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,KCNQ1;HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,4,5,4
13,Waist-hip Index,5.84779052088106e-06,8.311163101604278,100.1449164487547,HLA-DRA;BTNL2;IGF2BP2;APOE;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.00037025315631144796,GWAS_Catalog_2023,HLA-DRA;BTNL2;APOE;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;IGF2BP2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,8,8,7
14,Two-hour Glucose,6.16354838092779e-06,106.8375,1281.7143070022444,GIPR;KCNQ1;IGF2BP2,0.00037025315631144796,GWAS_Catalog_2023,GIPR,GIPR;KCNQ1;IGF2BP2,GIPR,1,3,1
11,Asthma (Adult Onset),5.416073262819622e-06,40.834871794871795,495.1693516588297,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.00037025315631144796,GWAS_Catalog_2023,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,4,4,4
27,"Alzheimer Disease, Early Onset",4.857850383224604e-06,23.525367472735894,287.8308602187795,IDUA;PLCG2;TREM2;APOE;PICALM,0.00039258627911837354,DisGeNET,IDUA;PLCG2;TREM2;APOE;PICALM,,,5,0,0
28,Steroid-sensitive nephrotic syndrome,5.0834725797279014e-06,115.06153846153846,1402.5444584489262,PLCG2;HLA-DQA1;HLA-DQB1,0.00039614775603451,DisGeNET,PLCG2;HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,3,2,2
29,"Hallucinations, Sensory",5.831765698965704e-06,40.032176973353444,482.4754325858409,GRN;TREM2;HLA-DRB1;HLA-DQB1,0.0004135839571299805,DisGeNET,GRN;TREM2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,2,2
31,Schizophrenia,5.8758490701326285e-06,5.067666217430368,61.03831651047737,CDKN1C;GRN;GIPR;TREM2;NPAS1;CCND2;MTNR1B;IGF2BP2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;PICALM;HLA-DQB1,0.0004135839571299805,DisGeNET,GRN;GIPR;TREM2;NPAS1;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;PICALM;HLA-DQB1,CDKN1C;GIPR;NPAS1;CCND2;MTNR1B;IGF2BP2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,GIPR;NPAS1;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,11,11,7
30,Systemic onset juvenile chronic arthritis,5.831765698965704e-06,40.032176973353444,482.4754325858409,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.0004135839571299805,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,4,4,4
15,Fasting Glucose,8.802118302802596e-06,20.70906432748538,241.064239157459,MTNR1B;QPCTL;KCNQ1;IGF2BP2;JAZF1,0.0004935054328437989,GWAS_Catalog_2023,QPCTL;JAZF1,MTNR1B;QPCTL;KCNQ1;IGF2BP2;JAZF1,QPCTL;JAZF1,2,5,2
16,Triglycerides,1.084754445302875e-05,10.767498430634024,123.08943164536338,CCND2;GIPR;ZC3H4;HLA-DRA;APOE;HLA-DRB1;HLA-DQA1,0.0005638554410020608,GWAS_Catalog_2023,GIPR;ZC3H4;HLA-DRA;APOE;HLA-DRB1;HLA-DQA1,CCND2;GIPR;ZC3H4;HLA-DRA;HLA-DRB1;HLA-DQA1,GIPR;ZC3H4;HLA-DRA;HLA-DRB1;HLA-DQA1,6,6,5
17,Alzheimer's Disease (Late Onset),1.1397791316331788e-05,33.452711223203025,380.7618021856374,PLCG2;TREM2;APOE;HLA-DRB1,0.0005638554410020608,GWAS_Catalog_2023,PLCG2;TREM2;APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,4,1,1
33,Anti-Glomerular Basement Membrane Disease,8.756780424589562e-06,93.4734375,1088.56195212828,HLA-DQB2;HLA-DRB1;HLA-DQB1,0.0005790089359531644,DisGeNET,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,3,3,3
32,Somnolence,8.756780424589562e-06,93.4734375,1088.56195212828,APOE;HLA-DRB1;HLA-DQB1,0.0005790089359531644,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
34,Autoimmune thyroid disease,9.134180010800497e-06,20.544964774140073,238.3932344585508,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0005861994348107847,DisGeNET,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,5,5,5
18,Type 2 Diabetes (Adjusted For BMI),1.2863331729415559e-05,32.38746438746439,364.71944022317945,GIPR;KCNQ1;SLC22A18;IGF2BP2,0.0006010034435799159,GWAS_Catalog_2023,GIPR,GIPR;KCNQ1;SLC22A18;IGF2BP2,GIPR,1,4,1
19,Glycated Hemoglobin HbA1c Levels,1.3854455888142476e-05,78.70263157894736,880.4387566559598,MTNR1B;KCNQ1;IGF2BP2,0.000613241968522517,GWAS_Catalog_2023,,MTNR1B;KCNQ1;IGF2BP2,,0,3,0
35,Rheumatic Fever,1.0059171925549804e-05,34.59017818339852,398.0300696782971,CDKN2B;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.0006271175183299906,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN2B;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,4,3
15,Membranous glomerulonephritis,6.735595509725685e-05,243.32926829268294,2337.303967964173,HLA-DQA2;HLA-DQA1,0.0006331459779142144,Jensen_DISEASES,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,2,2,2
36,Autoimmune Diseases,1.056509005964641e-05,6.196020019065777,70.99372092810948,GRN;PLCG2;HLA-DRA;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.000640361847504124,DisGeNET,GRN;PLCG2;HLA-DRA;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,11,8,8
20,Ulcerative Colitis,1.643896222622291e-05,18.103983918128655,199.43088521370046,PLCG2;HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,0.0006860755720189571,GWAS_Catalog_2023,PLCG2;HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DQA1;HLA-DQB1,5,4,4
21,Blood Glucose Levels,1.7131494663969202e-05,29.998491704374057,329.2212069287722,CCND2;GIPR;KCNQ1;JAZF1,0.0006860755720189571,GWAS_Catalog_2023,GIPR;JAZF1,CCND2;GIPR;KCNQ1;JAZF1,GIPR;JAZF1,2,4,2
22,Fasting Plasma Glucose,2.123144935623196e-05,28.326210826210826,304.7907937318705,MTNR1B;GIPR;KCNQ1;IGF2BP2,0.0008116204049359581,GWAS_Catalog_2023,GIPR,MTNR1B;GIPR;KCNQ1;IGF2BP2,GIPR,1,4,1
1,beckwith-wiedemann syndrome,6.735595509725685e-05,243.32926829268294,2337.303967964173,CDKN1C;KCNQ1,0.0010103393264588529,ClinVar_2019,,CDKN1C;KCNQ1,,0,2,0
16,Dementia,0.00012289573606051108,17.696321070234113,159.34075825923392,GRN;TREM2;APOE;PICALM,0.001022965763643578,Jensen_DISEASES,GRN;TREM2;APOE;PICALM,,,4,0,0
17,Beckwith-Wiedemann syndrome,0.00012333629774426117,35.5625,320.08368833375835,CDKN1C;KCNQ1;SLC22A18,0.001022965763643578,Jensen_DISEASES,,CDKN1C;KCNQ1;SLC22A18,,0,3,0
38,Behavioral variant of frontotemporal dementia,1.8154235584669403e-05,71.2,777.2623941159866,GRN;TREM2;APOE,0.0010348859069288215,DisGeNET,GRN;TREM2;APOE,,,3,0,0
39,Ulcerative Colitis,1.8497044166005515e-05,6.379373848987108,69.52177580296704,IDUA;PLCG2;HLA-DRA;BTNL2;APOE;IL17RD;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,0.0010348859069288215,DisGeNET,IDUA;PLCG2;HLA-DRA;BTNL2;APOE;IL17RD;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,10,6,6
37,Inflammatory Bowel Diseases,1.7810072897318838e-05,6.409040460094844,70.08764093138335,GRN;IDUA;PLCG2;TREM2;BTNL2;APOE;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.0010348859069288215,DisGeNET,GRN;IDUA;PLCG2;TREM2;BTNL2;APOE;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,10,5,5
19,Primary immunodeficiency disease,0.00016099400163033776,139.02439024390245,1214.2589675263725,HLA-DQA1;HLA-DRB1,0.0011947449594672435,Jensen_DISEASES,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
18,IgA glomerulonephritis,0.00016099400163033776,139.02439024390245,1214.2589675263725,HLA-DRB1;HLA-DQB1,0.0011947449594672435,Jensen_DISEASES,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
40,Systemic Scleroderma,2.2524512122355895e-05,8.005363589479114,85.66464658177404,ATP8B4;GRN;HLA-DRA;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.001228712136274514,DisGeNET,ATP8B4;GRN;HLA-DRA;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,8,5,5
20,Lung cancer,0.00020095784945236813,8.051721772533956,68.53960022070409,ATP8B4;MTNR1B;PLCG2;HLA-DRA;BTNL2;HLA-DRB1,0.0014167528386391953,Jensen_DISEASES,ATP8B4;PLCG2;HLA-DRA;BTNL2;HLA-DRB1,MTNR1B;HLA-DRA;BTNL2;HLA-DRB1,HLA-DRA;BTNL2;HLA-DRB1,5,4,3
23,Hemoglobin A1c Levels,4.2185930640259134e-05,10.808245533669263,108.87603768336932,CCND2;MTNR1B;ZC3H4;KCNQ1;IGF2BP2;JAZF1,0.0015126305437015539,GWAS_Catalog_2023,ZC3H4;JAZF1,CCND2;MTNR1B;ZC3H4;KCNQ1;IGF2BP2;JAZF1,ZC3H4;JAZF1,2,6,2
24,Asthma,4.458133836934389e-05,10.697805187738073,107.1727006755456,SHARPIN;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.0015126305437015539,GWAS_Catalog_2023,SHARPIN;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,6,5,5
25,Entorhinal Cortical Thickness,4.496523613857176e-05,324.4552845528455,3247.674396403277,SHARPIN;APOE,0.0015126305437015539,GWAS_Catalog_2023,SHARPIN;APOE,,,2,0,0
41,Prediabetes syndrome,2.867516633613683e-05,26.13938198553583,273.4043194137663,MTNR1B;HLA-DRA;IGF2BP2;APPL1,0.0015260783645231844,DisGeNET,HLA-DRA;APPL1,MTNR1B;HLA-DRA;IGF2BP2,HLA-DRA,2,3,1
21,Dermatomyositis,0.00024529265118944116,108.11924119241192,898.8015841018229,HLA-DQA1;HLA-DRB1,0.0016469649437005336,Jensen_DISEASES,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
43,Acute Confusional Senile Dementia,3.304077574106036e-05,25.167458056346945,259.6719966655491,PLCG2;TREM2;APOE;PICALM,0.001676627271325435,DisGeNET,PLCG2;TREM2;APOE;PICALM,,,4,0,0
42,"Alzheimer's Disease, Focal Onset",3.304077574106036e-05,25.167458056346945,259.6719966655491,PLCG2;TREM2;APOE;PICALM,0.001676627271325435,DisGeNET,PLCG2;TREM2;APOE;PICALM,,,4,0,0
26,Systemic Lupus Erythematosus,5.336653066054909e-05,10.345208845208845,101.77954517638686,HLA-DRA;BTNL2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.0017262020109816071,GWAS_Catalog_2023,HLA-DRA;BTNL2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,6,6,6
27,Hay Fever And/Or Eczema,5.5492738682249425e-05,21.906810035842295,214.67049182992716,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.0017284960456211765,GWAS_Catalog_2023,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,4,4,4
44,Narcolepsy-Cataplexy Syndrome,3.609024832058106e-05,55.361111111111114,566.3158139575121,HLA-DQB2;HLA-DRB1;HLA-DQB1,0.00178974822353427,DisGeNET,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,3,3,3
28,Total Cholesterol Levels,6.237653953500452e-05,6.06950909860347,58.76693736113996,CCND2;GIPR;QPCTL;SLC22A18;HLA-DRA;APOE;HLA-DQA1;HLA-DQB1;JAZF1,0.0018735239196049573,GWAS_Catalog_2023,GIPR;QPCTL;HLA-DRA;APOE;HLA-DQA1;HLA-DQB1;JAZF1,CCND2;GIPR;QPCTL;SLC22A18;HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,GIPR;QPCTL;HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,7,8,6
46,Opportunistic Infections,3.989725268674927e-05,53.38125,540.7095225232104,APOE;HLA-DRB1;HLA-DQB1,0.00189251750788015,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
45,Creutzfeldt-Jakob disease,3.959534275652103e-05,23.978280542986425,243.06301151938413,GRN;TREM2;APOE;HLA-DQB1,0.00189251750788015,DisGeNET,GRN;TREM2;APOE;HLA-DQB1,HLA-DQB1,HLA-DQB1,4,1,1
29,Acute Insulin Response,6.735595509725685e-05,243.32926829268294,2337.303967964173,MTNR1B;IGF2BP2,0.0019533226978204485,GWAS_Catalog_2023,,MTNR1B;IGF2BP2,,0,2,0
47,Cataplexy,4.395866073546934e-05,51.53793103448276,517.0419700965106,HLA-DQB2;HLA-DRB1;HLA-DQB1,0.002040804206910513,DisGeNET,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,HLA-DQB2;HLA-DRB1;HLA-DQB1,3,3,3
49,"Nephritis, Interstitial",4.8282154573672834e-05,49.8175,495.1086599472201,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.0021070332255950825,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
48,Adrenocortical carcinoma,4.643221983025662e-05,14.45687134502924,144.24367884299386,CDKN1C;GRN;GIPR;KCNQ1;HLA-DRB1,0.0021070332255950825,DisGeNET,GRN;GIPR;HLA-DRB1,CDKN1C;GIPR;KCNQ1;HLA-DRB1,GIPR;HLA-DRB1,3,4,2
50,Pemphigus,4.8282154573672834e-05,49.8175,495.1086599472201,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.0021070332255950825,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
22,Vitiligo,0.0003359871776924858,24.87125,198.93114017307255,BTNL2;HLA-DRB1;HLA-DQA1,0.0021533723661200225,Jensen_DISEASES,BTNL2;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,3,3,3
51,Membranous glomerulonephritis,5.114661231669348e-05,22.390532544378697,221.2366941071893,BTNL2;APOE;HLA-DRB1;HLA-DQA1,0.0021882727073534347,DisGeNET,BTNL2;APOE;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,4,3,3
30,Medication Use (Drugs Used In Diabetes),8.13748924347489e-05,19.769977595220315,186.16288254307304,CCND2;KCNQ1;IGF2BP2;JAZF1,0.002281209484587461,GWAS_Catalog_2023,JAZF1,CCND2;KCNQ1;IGF2BP2;JAZF1,JAZF1,1,4,1
31,Family History Of Alzheimer's Disease,8.65199983160333e-05,40.37837837837838,377.745179855569,APH1B;APOE;ALPK2,0.002347203825283355,GWAS_Catalog_2023,APH1B;APOE;ALPK2,,,3,0,0
52,"COLORBLINDNESS, PARTIAL, DEUTAN SERIES",5.774588151383535e-05,46.69921875,455.7590886284715,APOE;HLA-DRB1;HLA-DQB1,0.002378136768294028,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
53,Frontotemporal Lobar Degeneration,5.776409198881003e-05,21.67266775777414,211.50666863376287,GRN;TREM2;APOE;HLA-DRB1,0.002378136768294028,DisGeNET,GRN;TREM2;APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,4,1,1
33,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) Levels In Elite Athletes,9.416979940433038e-05,194.65365853658537,1804.5194228526939,KCNQ1;ALPK2,0.0023999030696679347,GWAS_Catalog_2023,ALPK2,KCNQ1,,1,1,0
32,Complement C4 Levels (C4A.C4B.4481.34.2),9.416979940433038e-05,194.65365853658537,1804.5194228526939,HLA-DRB1;HLA-DQA1,0.0023999030696679347,GWAS_Catalog_2023,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,2,2,2
34,Hip Circumference Adjusted For BMI,0.00010306163978234728,5.664289958407606,51.99922010656095,KCNQ1;HLA-DRA;IGF2BP3;BTNL2;IGF2BP2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.002549259972263355,GWAS_Catalog_2023,HLA-DRA;BTNL2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,KCNQ1;HLA-DRA;IGF2BP3;BTNL2;IGF2BP2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,6,9,6
55,Varicella Zoster Virus Infection,6.735595509725685e-05,243.32926829268294,2337.303967964173,HLA-DRB1;HLA-DQB1,0.002616444127224198,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
57,Leukoaraiosis,6.834890708147538e-05,43.94779411764706,421.4982387246933,GRN;TREM2;APOE,0.002616444127224198,DisGeNET,GRN;TREM2;APOE,,,3,0,0
56,Localized vitiligo,6.735595509725685e-05,243.32926829268294,2337.303967964173,HLA-DQA1;HLA-DRB1,0.002616444127224198,DisGeNET,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
54,Impaired glucose tolerance,6.568636168008754e-05,9.951182432432432,95.83604898259614,MTNR1B;IGF2BP2;APOE;PICALM;HLA-DQB1;NEUROG3,0.002616444127224198,DisGeNET,APOE;PICALM;HLA-DQB1,MTNR1B;IGF2BP2;HLA-DQB1;NEUROG3,HLA-DQB1,3,4,1
35,Cholesteryl Ester Levels In Very Small VLDL,0.00011528633399315588,36.43170731707317,330.36606140387784,APOE;HLA-DQB1;JAZF1,0.0027701659110926885,GWAS_Catalog_2023,APOE;HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,3,2,2
58,Idiopathic Membranous Glomerulonephritis,7.409634139154903e-05,42.69,405.9880644707658,HLA-DQA2;HLA-DQA1;HLA-DRB1,0.002787555464075172,DisGeNET,HLA-DQA2;HLA-DQA1;HLA-DRB1,HLA-DQA2;HLA-DQA1;HLA-DRB1,HLA-DQA2;HLA-DQA1;HLA-DRB1,3,3,3
23,Autoimmune thyroiditis,0.00046573681352710507,74.83677298311444,574.139479895918,HLA-DQA1;PICALM,0.002855169161187905,Jensen_DISEASES,HLA-DQA1;PICALM,HLA-DQA1,HLA-DQA1,2,1,1
59,Sense of smell impaired,8.015092485645338e-05,41.50208333333333,391.43101347094785,HESX1;APOE;IL17RD,0.002914821967279688,DisGeNET,HESX1;APOE;IL17RD,,,3,0,0
60,Anosmia,8.015092485645338e-05,41.50208333333333,391.43101347094785,HESX1;APOE;IL17RD,0.002914821967279688,DisGeNET,HESX1;APOE;IL17RD,,,3,0,0
36,Peak Insulin Response,0.0001253885401588909,162.20325203252034,1457.2491531056257,MTNR1B;IGF2BP2,0.002929215618711868,GWAS_Catalog_2023,,MTNR1B;IGF2BP2,,0,2,0
1,celiac disease,0.0004041897176269234,81.07723577235772,633.5072130174765,HLA-DQA1;HLA-DQB1,0.003233517741015387,OMIM_Disease,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
66,Diffuse Scleroderma,0.00010023073893269744,38.30384615384615,352.7031805560676,HLA-DQA1;HLA-DRB1;HLA-DQB1,0.003313688975017361,DisGeNET,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,HLA-DQA1;HLA-DRB1;HLA-DQB1,3,3,3
61,Physical Activity Measurement,9.385103813034023e-05,19.027078840162954,176.45335672947346,GIPR;ZC3H4;KCNQ1;JAZF1,0.003313688975017361,DisGeNET,GIPR;ZC3H4;JAZF1,GIPR;ZC3H4;KCNQ1;JAZF1,GIPR;ZC3H4;JAZF1,3,4,3
64,Reduced bone mineral density,0.00010023073893269744,38.30384615384615,352.7031805560676,HESX1;TREM2;IL17RD,0.003313688975017361,DisGeNET,HESX1;TREM2;IL17RD,,,3,0,0
65,Oligoarticular Juvenile Idiopathic Arthritis,0.00010023073893269744,38.30384615384615,352.7031805560676,HLA-DQA1;HLA-DRB1;JAZF1,0.003313688975017361,DisGeNET,HLA-DQA1;HLA-DRB1;JAZF1,HLA-DQA1;HLA-DRB1;JAZF1,HLA-DQA1;HLA-DRB1;JAZF1,3,3,3
62,Parasomnia,9.416979940433038e-05,194.65365853658537,1804.5194228526939,HLA-DQB2;HLA-DQB1,0.003313688975017361,DisGeNET,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,2,2,2
63,"Lupus Erythematosus, Systemic",9.735527578752515e-05,5.179812632215171,47.8466732788959,CDKN1C;GRN;HLA-DRA;BTNL2;APOE;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.003313688975017361,DisGeNET,GRN;HLA-DRA;BTNL2;APOE;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,CDKN1C;HLA-DRA;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,9,8,7
67,Acute lymphocytic leukemia,0.00010933045420186533,5.618072841608804,51.243204042328436,CDKN1C;CDKN2B;CCND2;IGF2BP3;IGF2BP2;HLA-DRB1;HLA-DQA1;PICALM;HLA-DQB1,0.0035605828517682116,DisGeNET,HLA-DRB1;HLA-DQA1;PICALM;HLA-DQB1,CDKN1C;CDKN2B;CCND2;IGF2BP3;IGF2BP2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,4,8,3
37,Autism Spectrum Disorder Or Schizophrenia,0.00015796536596751328,16.538670002084636,144.7652071421949,HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.0035905100750994235,GWAS_Catalog_2023,HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,4,4,4
70,Neuromyelitis Optica,0.00011528633399315588,36.43170731707317,330.36606140387784,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.003593639725329516,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
69,Brittle diabetes,0.00011528633399315588,36.43170731707317,330.36606140387784,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.003593639725329516,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
68,Apraxias,0.00011528633399315588,36.43170731707317,330.36606140387784,GRN;TREM2;APOE,0.003593639725329516,DisGeNET,GRN;TREM2;APOE,,,3,0,0
73,Overgrowth of external genitalia,0.0001253885401588909,162.20325203252034,1457.2491531056257,CDKN1C;KCNQ1,0.003697267494955405,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
71,Delirium,0.00012333629774426117,35.5625,320.08368833375835,GRN;MTNR1B;APOE,0.003697267494955405,DisGeNET,GRN;APOE,MTNR1B,,2,1,0
72,Adrenocortical cytomegaly,0.0001253885401588909,162.20325203252034,1457.2491531056257,CDKN1C;KCNQ1,0.003697267494955405,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
74,Pancreatic hyperplasia,0.0001253885401588909,162.20325203252034,1457.2491531056257,CDKN1C;KCNQ1,0.003697267494955405,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
38,Hip Circumference,0.0001728124079853278,16.14245014245014,139.8469512536839,SNRPD2;GIPR;ZC3H4;ALPK2,0.0038246114504121233,GWAS_Catalog_2023,SNRPD2;GIPR;ZC3H4;ALPK2,SNRPD2;GIPR;ZC3H4,SNRPD2;GIPR;ZC3H4,4,3,3
75,"Diabetes Mellitus, Ketosis-Prone",0.00013174379581985435,34.73372093023256,310.3336904970528,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.0038328661663856295,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
78,IGA Glomerulonephritis,0.0001493391205772409,11.187046279491833,98.54994455266213,CDKN1C;HLA-DRA;APOE;HLA-DRB1;HLA-DQB1,0.003991919449515875,DisGeNET,HLA-DRA;APOE;HLA-DRB1;HLA-DQB1,CDKN1C;HLA-DRA;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB1,4,4,3
88,Ocular Cicatricial Pemphigoid,0.00016099400163033776,139.02439024390245,1214.2589675263725,HLA-DRB1;HLA-DQB1,0.003991919449515875,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
87,Mild hereditary factor VIII deficiency disease,0.00016099400163033776,139.02439024390245,1214.2589675263725,HLA-DRA;HLA-DRB1,0.003991919449515875,DisGeNET,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
86,Abnormal rapid eye movement sleep,0.00016099400163033776,139.02439024390245,1214.2589675263725,HLA-DRB1;HLA-DQB1,0.003991919449515875,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
85,Spoken Word Recognition Deficit,0.00016099400163033776,139.02439024390245,1214.2589675263725,GRN;TREM2,0.003991919449515875,DisGeNET,GRN;TREM2,,,2,0,0
79,Overweight,0.00015230253796766054,11.138468488818614,97.90314636760809,MTNR1B;GIPR;IGF2BP2;APOE;HLA-DQA1,0.003991919449515875,DisGeNET,GIPR;APOE;HLA-DQA1,MTNR1B;GIPR;IGF2BP2;HLA-DQA1,GIPR;HLA-DQA1,3,4,2
77,Sarcoidosis,0.0001464201064767919,11.236044657097288,99.2033823987381,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.003991919449515875,DisGeNET,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
84,Grammar-specific speech disorder,0.00016099400163033776,139.02439024390245,1214.2589675263725,GRN;TREM2,0.003991919449515875,DisGeNET,GRN;TREM2,,,2,0,0
83,Gluten sensitivity,0.00016099400163033776,139.02439024390245,1214.2589675263725,HLA-DQA2;HLA-DQA1,0.003991919449515875,DisGeNET,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,2,2,2
82,Senile Paranoid Dementia,0.00016099400163033776,139.02439024390245,1214.2589675263725,GRN;TREM2,0.003991919449515875,DisGeNET,GRN;TREM2,,,2,0,0
81,Allergic disposition,0.00015836441742673134,11.042553191489361,96.62909561111405,CDKN2B;HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.003991919449515875,DisGeNET,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN2B;HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,4,5,4
80,Glaucoma,0.00015438765564128928,8.467891891891892,74.31459076420612,CDKN2B;CCND2;IDUA;APOE;HLA-DRB1;HLA-DQB1,0.003991919449515875,DisGeNET,IDUA;APOE;HLA-DRB1;HLA-DQB1,CDKN2B;CCND2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,4,2
76,Hepatoblastoma,0.00014354503973751902,11.285469107551487,99.86355542280602,CDKN1C;CDKN2B;KCNQ1;SLC22A18;APOE,0.003991919449515875,DisGeNET,APOE,CDKN1C;CDKN2B;KCNQ1;SLC22A18,,1,4,0
39,Nonatopic Asthma,0.00019008625754043913,30.47142857142857,261.08019342249946,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.004099039553628444,GWAS_Catalog_2023,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
89,Vitiligo,0.00016780178863595933,10.90170278637771,94.7655272980459,PLCG2;BTNL2;APOE;HLA-DRB1;HLA-DQA1,0.004113971941614194,DisGeNET,PLCG2;BTNL2;APOE;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,5,3,3
40,Alzheimer's Disease (Age Of Onset),0.0002009680615243086,121.64024390243902,1035.4461013159446,TREM2;APOE,0.004122296091266915,GWAS_Catalog_2023,TREM2;APOE,,,2,0,0
41,Gestational Diabetes Mellitus,0.0002009680615243086,121.64024390243902,1035.4461013159446,MTNR1B;IGF2BP2,0.004122296091266915,GWAS_Catalog_2023,,MTNR1B;IGF2BP2,,0,2,0
90,Uveitis,0.0001728124079853278,16.14245014245014,139.8469512536839,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.004189740824710947,DisGeNET,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,4,4,4
92,Pseudohyperkalemia Cardiff,0.000177978120582019,16.014536644457905,138.26710613967586,APOE;HLA-DQA2;HLA-DRB1;HLA-DQA1,0.004221176729456146,DisGeNET,APOE;HLA-DQA2;HLA-DRB1;HLA-DQA1,HLA-DQA2;HLA-DRB1;HLA-DQA1,HLA-DQA2;HLA-DRB1;HLA-DQA1,4,3,3
91,Disorder of eye,0.000177978120582019,16.014536644457905,138.26710613967586,APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.004221176729456146,DisGeNET,APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,4,3,3
97,Blunted affect,0.0002009680615243086,121.64024390243902,1035.4461013159446,GRN;TREM2,0.00441634819327593,DisGeNET,GRN;TREM2,,,2,0,0
96,"Toxoplasmosis, Cerebral",0.0002009680615243086,121.64024390243902,1035.4461013159446,HLA-DRB1;HLA-DQB1,0.00441634819327593,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
98,Dementia of frontal lobe type,0.0002009680615243086,121.64024390243902,1035.4461013159446,TREM2;APOE,0.00441634819327593,DisGeNET,TREM2;APOE,,,2,0,0
93,Seropositive rheumatoid arthritis,0.0002009680615243086,121.64024390243902,1035.4461013159446,HLA-DRB1;HLA-DQB1,0.00441634819327593,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
94,"HEMIHYPERPLASIA, ISOLATED",0.0002009680615243086,121.64024390243902,1035.4461013159446,CDKN1C;IDUA,0.00441634819327593,DisGeNET,IDUA,CDKN1C,,1,1,0
95,Temporal cortical atrophy,0.0002009680615243086,121.64024390243902,1035.4461013159446,GRN;TREM2,0.00441634819327593,DisGeNET,GRN;TREM2,,,2,0,0
99,EEG with continuous slow activity,0.0002009680615243086,121.64024390243902,1035.4461013159446,GRN;TREM2,0.00441634819327593,DisGeNET,GRN;TREM2,,,2,0,0
100,"Alzheimer Disease, Late Onset",0.0002023990922674578,10.456812393887946,88.93800339475749,GRN;PLCG2;TREM2;APOE;PICALM,0.00441634819327593,DisGeNET,GRN;PLCG2;TREM2;APOE;PICALM,,,5,0,0
101,Diffuse Large B-Cell Lymphoma,0.00020523970386451983,6.637470657276995,56.36096682370493,CDKN1C;CDKN2B;CCND2;PLCG2;HLA-DRB1;PICALM;HLA-DQB1,0.004433990433983983,DisGeNET,PLCG2;HLA-DRB1;PICALM;HLA-DQB1,CDKN1C;CDKN2B;CCND2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,5,2
42,Eosinophil Counts,0.00022278944239134945,5.680236861584012,47.766721758748,TOX2;SHARPIN;HLA-DRA;ALPK2;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.004461093358360117,GWAS_Catalog_2023,SHARPIN;HLA-DRA;ALPK2;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,TOX2;HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQA1;HLA-DQB1,7,5,4
45,Response To Hepatitis B Vaccine,0.00024529265118944116,108.11924119241192,898.8015841018229,BTNL2;HLA-DQA1,0.004584247103340445,GWAS_Catalog_2023,BTNL2;HLA-DQA1,BTNL2;HLA-DQA1,BTNL2;HLA-DQA1,2,2,2
44,Moderate To Vigorous Physical Activity Levels,0.00024529265118944116,108.11924119241192,898.8015841018229,APOE;HLA-DQB1,0.004584247103340445,GWAS_Catalog_2023,APOE;HLA-DQB1,HLA-DQB1,HLA-DQB1,2,1,1
43,Total Testosterone Levels,0.00023876631980728532,7.7893618434158975,64.96347426639448,ZC3H4;QPCTL;SLC22A18;JADE2;HLA-DQA1;JAZF1,0.004584247103340445,GWAS_Catalog_2023,ZC3H4;QPCTL;HLA-DQA1;JAZF1,ZC3H4;QPCTL;SLC22A18;JADE2;HLA-DQA1;JAZF1,ZC3H4;QPCTL;HLA-DQA1;JAZF1,4,6,4
102,Psoriasis vulgaris,0.00021731712578879178,15.172598545732875,127.96801544965346,GRN;BTNL2;APOE;HLA-DRB1,0.004648882043834741,DisGeNET,GRN;BTNL2;APOE;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,4,2,2
24,Alzheimer's disease,0.0008032099177403704,10.61404215330917,75.6451582346225,ATP8B4;APOE;PVRL2;PICALM,0.0047188582667246765,Jensen_DISEASES,ATP8B4;APOE;PVRL2;PICALM,,,4,0,0
25,Aphasia,0.0008370330222898128,54.03523035230352,382.87456973669936,GRN;APOE,0.004720866245714544,Jensen_DISEASES,GRN;APOE,,,2,0,0
104,Mycosis Fungoides,0.00024242034731166733,14.729840208101077,122.6235241631035,CDKN2B;HLA-DRB1;HLA-DQB2;HLA-DQB1,0.004778826472280006,DisGeNET,HLA-DRB1;HLA-DQB2;HLA-DQB1,CDKN2B;HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,3,4,3
105,Eosinophilia-Myalgia Syndrome,0.00024529265118944116,108.11924119241192,898.8015841018229,HLA-DQA1;HLA-DRB1,0.004778826472280006,DisGeNET,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
106,Hyperorality,0.00024529265118944116,108.11924119241192,898.8015841018229,GRN;TREM2,0.004778826472280006,DisGeNET,GRN;TREM2,,,2,0,0
107,Alexia,0.00024529265118944116,108.11924119241192,898.8015841018229,GRN;TREM2,0.004778826472280006,DisGeNET,GRN;TREM2,,,2,0,0
108,Asymmetric overgrowth,0.00024529265118944116,108.11924119241192,898.8015841018229,CDKN1C;KCNQ1,0.004778826472280006,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
109,Pathological Dilatation,0.00024529265118944116,108.11924119241192,898.8015841018229,HLA-DRB1;HLA-DQB1,0.004778826472280006,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
110,Posterior helix pit,0.00024529265118944116,108.11924119241192,898.8015841018229,CDKN1C;KCNQ1,0.004778826472280006,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
111,Postherpetic neuralgia,0.00024529265118944116,108.11924119241192,898.8015841018229,APOE;HLA-DRB1,0.004778826472280006,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
103,"Lymphoma, T-Cell, Cutaneous",0.00022968286180705802,10.166150670794634,85.18025570099593,CDKN1C;CDKN2B;CCND2;HLA-DRB1;HLA-DQB1,0.004778826472280006,DisGeNET,HLA-DRB1;HLA-DQB1,CDKN1C;CDKN2B;CCND2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,5,2
112,Difficulty making arithmetical calculations,0.00024529265118944116,108.11924119241192,898.8015841018229,GRN;TREM2,0.004778826472280006,DisGeNET,GRN;TREM2,,,2,0,0
113,Leprosy,0.0002490087681467491,14.623132263420032,121.34307979185846,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.004808293204391209,DisGeNET,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,4,4,4
26,Celiac disease,0.0008944087786701765,17.534117647058824,123.07806733345828,ALPK2;HLA-DQA1;HLA-DQB1,0.00485044760740365,Jensen_DISEASES,ALPK2;HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,3,2,2
49,Body Mass Index And Type 2 Diabetes (Pairwise),0.0002939497556798544,97.30243902439024,791.2733302207097,IGF2BP2;JAZF1,0.004939527661650218,GWAS_Catalog_2023,JAZF1,IGF2BP2;JAZF1,JAZF1,1,2,1
47,Multiple Sclerosis,0.00027812068625435583,9.740304709141274,79.74831053714851,TOX2;ALPK2;JADE2;HLA-DQA1;JAZF1,0.004939527661650218,GWAS_Catalog_2023,ALPK2;HLA-DQA1;JAZF1,TOX2;JADE2;HLA-DQA1;JAZF1,HLA-DQA1;JAZF1,3,4,2
48,"Alzheimer's Disease, Proxy Alzheimer's Disease Or Related Dementias",0.0002939497556798544,97.30243902439024,791.2733302207097,TREM2;APOE,0.004939527661650218,GWAS_Catalog_2023,TREM2;APOE,,,2,0,0
50,Cholesteryl Esters To Total Lipids Ratio In Small VLDL,0.00030541669251582797,25.73146551724138,208.26619783387193,GIPR;APOE;HLA-DQA1,0.004939527661650218,GWAS_Catalog_2023,GIPR;APOE;HLA-DQA1,GIPR;HLA-DQA1,GIPR;HLA-DQA1,3,2,2
51,Takayasu Arteritis,0.00030541669251582797,25.73146551724138,208.26619783387193,PLCG2;HLA-DQB2;HLA-DQB1,0.004939527661650218,GWAS_Catalog_2023,PLCG2;HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,3,2,2
52,Cholesteryl Esters To Total Lipids Ratio In Medium VLDL,0.00030541669251582797,25.73146551724138,208.26619783387193,GIPR;APOE;HLA-DQA1,0.004939527661650218,GWAS_Catalog_2023,GIPR;APOE;HLA-DQA1,GIPR;HLA-DQA1,GIPR;HLA-DQA1,3,2,2
46,Free Cholesterol To Total Lipids Ratio In Medium VLDL,0.00027670290974554537,26.653125,218.35748980907536,GIPR;APOE;HLA-DQA1,0.004939527661650218,GWAS_Catalog_2023,GIPR;APOE;HLA-DQA1,GIPR;HLA-DQA1,GIPR;HLA-DQA1,3,2,2
115,Nerve Degeneration,0.00026257096906837215,14.414257137661393,118.84539376467356,GRN;IDUA;TREM2;APOE,0.004969790930281587,DisGeNET,GRN;IDUA;TREM2;APOE,,,4,0,0
116,Hypothyroidism,0.00026420520069324663,9.852911747048228,81.17601639805463,KCNQ1;HESX1;APOE;HLA-DRB1;HLA-DQB1,0.004969790930281587,DisGeNET,HESX1;APOE;HLA-DRB1;HLA-DQB1,KCNQ1;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,3,2
114,Frontotemporal dementia,0.00026257096906837215,14.414257137661393,118.84539376467356,GRN;TREM2;BTNL2;APOE,0.004969790930281587,DisGeNET,GRN;TREM2;BTNL2;APOE,BTNL2,BTNL2,4,1,1
121,Recurrent respiratory papillomatosis,0.0002939497556798544,97.30243902439024,791.2733302207097,HLA-DRB1;HLA-DQB1,0.004972080363515058,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
118,SVEINSSON CHORIORETINAL ATROPHY,0.00027670290974554537,26.653125,218.35748980907536,HLA-DRB1;HLA-DQB2;HLA-DQB1,0.004972080363515058,DisGeNET,HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,3,3,3
119,Libman-Sacks Disease,0.00027670290974554537,26.653125,218.35748980907536,HLA-DRB1;HLA-DQA1;JAZF1,0.004972080363515058,DisGeNET,HLA-DRB1;HLA-DQA1;JAZF1,HLA-DRB1;HLA-DQA1;JAZF1,HLA-DRB1;HLA-DQA1;JAZF1,3,3,3
120,Oropharyngeal Carcinoma,0.00029083087231990317,26.18421052631579,213.21196871726985,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.004972080363515058,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
122,Frontotemporal cerebral atrophy,0.0002939497556798544,97.30243902439024,791.2733302207097,GRN;TREM2,0.004972080363515058,DisGeNET,GRN;TREM2,,,2,0,0
123,"Myasthenia Gravis, Ocular",0.0002939497556798544,97.30243902439024,791.2733302207097,HLA-DQA1;HLA-DRB1,0.004972080363515058,DisGeNET,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
124,"Restrictive behavior, interests, and activities",0.0002939497556798544,97.30243902439024,791.2733302207097,GRN;TREM2,0.004972080363515058,DisGeNET,GRN;TREM2,,,2,0,0
117,"Glaucoma, Primary Open Angle",0.0002766567746533795,14.211224672763134,116.42876793643745,CDKN2B;APOE;HLA-DRB1;HLA-DQB1,0.004972080363515058,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,CDKN2B;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,3,2
125,Abnormal brain FDG positron emission tomography,0.0002939497556798544,97.30243902439024,791.2733302207097,GRN;TREM2,0.004972080363515058,DisGeNET,GRN;TREM2,,,2,0,0
127,Lack of insight,0.0002939497556798544,97.30243902439024,791.2733302207097,GRN;TREM2,0.004972080363515058,DisGeNET,GRN;TREM2,,,2,0,0
128,Berylliosis,0.0002939497556798544,97.30243902439024,791.2733302207097,BTNL2;HLA-DRB1,0.004972080363515058,DisGeNET,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,2,2,2
129,Developmental arithmetic disorder,0.0002939497556798544,97.30243902439024,791.2733302207097,GRN;TREM2,0.004972080363515058,DisGeNET,GRN;TREM2,,,2,0,0
126,Insulin measurement,0.0002939497556798544,97.30243902439024,791.2733302207097,GIPR;MTNR1B,0.004972080363515058,DisGeNET,GIPR,GIPR;MTNR1B,GIPR,1,2,1
130,Mild cognitive disorder,0.00029879307630711384,13.917105725324904,112.94787989424374,GRN;TREM2;APOE;PICALM,0.005015126865400942,DisGeNET,GRN;TREM2;APOE;PICALM,,,4,0,0
140,Neuro-degenerative disease,0.0003359871776924858,24.87125,198.93114017307255,IDUA;TREM2;APOE,0.005086290684541416,DisGeNET,IDUA;TREM2;APOE,,,3,0,0
141,"Hallucinations, Visual",0.00034692141370239296,88.45232815964523,704.6477129931925,GRN;APOE,0.005086290684541416,DisGeNET,GRN;APOE,,,2,0,0
142,Heymann Nephritis,0.00034692141370239296,88.45232815964523,704.6477129931925,HLA-DQA1;HLA-DRB1,0.005086290684541416,DisGeNET,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
143,Inappropriate behavior,0.00034692141370239296,88.45232815964523,704.6477129931925,GRN;TREM2,0.005086290684541416,DisGeNET,GRN;TREM2,,,2,0,0
139,Large fontanelle,0.0003359871776924858,24.87125,198.93114017307255,CDKN1C;KCNQ1;HESX1,0.005086290684541416,DisGeNET,HESX1,CDKN1C;KCNQ1,,1,2,0
131,Thickened facial skin with coarse facial features,0.0003064464687823347,13.821733821733822,111.8242878786689,CDKN1C;IDUA;KCNQ1;HESX1,0.005086290684541416,DisGeNET,IDUA;HESX1,CDKN1C;KCNQ1,,2,2,0
137,Wide bregma sutures,0.0003359871776924858,24.87125,198.93114017307255,CDKN1C;KCNQ1;HESX1,0.005086290684541416,DisGeNET,HESX1,CDKN1C;KCNQ1,,1,2,0
144,Beryllium Disease,0.00034692141370239296,88.45232815964523,704.6477129931925,BTNL2;HLA-DRB1,0.005086290684541416,DisGeNET,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,2,2,2
136,"Large, late-closing fontanelle",0.0003359871776924858,24.87125,198.93114017307255,CDKN1C;KCNQ1;HESX1,0.005086290684541416,DisGeNET,HESX1,CDKN1C;KCNQ1,,1,2,0
132,"Infant, Premature",0.0003127575046915473,9.487179487179487,76.56232032930447,EML2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.005086290684541416,DisGeNET,EML2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,EML2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,EML2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,5,5,5
133,Coarse facial features,0.00031423965646541486,13.727650727650728,110.71837130067722,CDKN1C;IDUA;KCNQ1;HESX1,0.005086290684541416,DisGeNET,IDUA;HESX1,CDKN1C;KCNQ1,,2,2,0
138,Large bregma sutures,0.0003359871776924858,24.87125,198.93114017307255,CDKN1C;KCNQ1;HESX1,0.005086290684541416,DisGeNET,HESX1,CDKN1C;KCNQ1,,1,2,0
134,nervous system disorder,0.00031924571016525897,7.364047768698931,59.27726703722372,CDKN2B;KCNQ1;TREM2;APOE;HLA-DRB1;HLA-DQB1,0.005086290684541416,DisGeNET,TREM2;APOE;HLA-DRB1;HLA-DQB1,CDKN2B;KCNQ1;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,4,2
145,Mediastinal lymphadenopathy,0.00034692141370239296,88.45232815964523,704.6477129931925,APOE;HLA-DRB1,0.005086290684541416,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
147,Diabetes in children,0.00034692141370239296,88.45232815964523,704.6477129931925,HLA-DQA1;HLA-DQB1,0.005086290684541416,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
146,Compulsive hoarding,0.00034692141370239296,88.45232815964523,704.6477129931925,GRN;TREM2,0.005086290684541416,DisGeNET,GRN;TREM2,,,2,0,0
151,Chronic Fatigue Syndrome,0.0003519843690952126,24.462295081967213,194.522306203946,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.005086290684541416,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
135,"Inclusion Body Myopathy, Sporadic",0.0003359871776924858,24.87125,198.93114017307255,BTNL2;APOE;HLA-DRB1,0.005086290684541416,DisGeNET,BTNL2;APOE;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,3,2,2
149,High-Grade Squamous Intraepithelial Lesions,0.0003519843690952126,24.462295081967213,194.522306203946,HLA-DRB1;HLA-DQB2;HLA-DQB1,0.005086290684541416,DisGeNET,HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,3,3,3
150,Allergic Reaction,0.0003519843690952126,24.462295081967213,194.522306203946,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.005086290684541416,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
148,Rheumatoid Arthritis,0.0003507289537576655,3.8552372854333847,30.67032805838523,GRN;MTNR1B;HLA-DRA;TREM2;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,0.005086290684541416,DisGeNET,GRN;HLA-DRA;TREM2;BTNL2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,MTNR1B;HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1;JAZF1,11,9,8
156,Gestational Diabetes,0.00040289798305519274,23.312109375,182.22672999558148,MTNR1B;IGF2BP2;PICALM,0.005377694901597237,DisGeNET,PICALM,MTNR1B;IGF2BP2,,1,2,0
164,Pure Red-Cell Aplasia,0.0004041897176269234,81.07723577235772,633.5072130174765,HLA-DRB1;HLA-DQB1,0.005377694901597237,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
163,Corticobasal degeneration,0.0004041897176269234,81.07723577235772,633.5072130174765,GRN;APOE,0.005377694901597237,DisGeNET,GRN;APOE,,,2,0,0
162,Congenital hemihypertrophy,0.0004041897176269234,81.07723577235772,633.5072130174765,CDKN1C;KCNQ1,0.005377694901597237,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
161,Angioedema,0.0004041897176269234,81.07723577235772,633.5072130174765,HLA-DRB1;HLA-DQB1,0.005377694901597237,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
155,Schistosomiasis,0.00040289798305519274,23.312109375,182.22672999558148,APOE;HLA-DRB1;HLA-DQB1,0.005377694901597237,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
160,Allergy to peanuts,0.0004041897176269234,81.07723577235772,633.5072130174765,HLA-DRB1;HLA-DQB1,0.005377694901597237,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
153,Beckwith-Wiedemann Syndrome,0.00038543363890109416,23.683333333333334,186.17803506279176,CDKN1C;KCNQ1;SLC22A18,0.005377694901597237,DisGeNET,,CDKN1C;KCNQ1;SLC22A18,,0,3,0
154,Nephritis,0.0004001906328909762,12.852320675105485,100.551024579804,CCND2;IL17RD;HLA-DRB1;HLA-DQB1,0.005377694901597237,DisGeNET,IL17RD;HLA-DRB1;HLA-DQB1,CCND2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,3,2
159,Genital ulcers,0.0004041897176269234,81.07723577235772,633.5072130174765,APOE;HLA-DRB1,0.005377694901597237,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
158,"Hydatidiform Mole, Partial",0.0004041897176269234,81.07723577235772,633.5072130174765,CDKN1C;HLA-DRB1,0.005377694901597237,DisGeNET,HLA-DRB1,CDKN1C;HLA-DRB1,HLA-DRB1,1,2,1
157,Renal cortical cysts,0.0004041897176269234,81.07723577235772,633.5072130174765,CDKN1C;KCNQ1,0.005377694901597237,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
152,GRN-related frontotemporal dementia,0.00038543363890109416,23.683333333333334,186.17803506279176,GRN;TREM2;APOE,0.005377694901597237,DisGeNET,GRN;TREM2;APOE,,,3,0,0
165,Recurrent infections,0.0004208635722139596,22.95230769230769,178.41292023227638,PLCG2;HLA-DRB1;HLA-DQB1,0.00556560190649006,DisGeNET,PLCG2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
53,Waist-hip Ratio,0.0003507564101949369,6.054392556808016,48.16522693695417,GIPR;QPCTL;BTNL2;IGF2BP2;APOE;IL17RD;JAZF1,0.005565776244791357,GWAS_Catalog_2023,GIPR;QPCTL;BTNL2;APOE;IL17RD;JAZF1,GIPR;QPCTL;BTNL2;IGF2BP2;JAZF1,GIPR;QPCTL;BTNL2;JAZF1,6,5,4
54,Waist Circumference,0.0003640184005452328,13.188811188811188,104.43304462432606,CCND2;GIPR;ZC3H4;QPCTL,0.005669249534417422,GWAS_Catalog_2023,GIPR;ZC3H4;QPCTL,CCND2;GIPR;ZC3H4;QPCTL,GIPR;ZC3H4;QPCTL,3,4,3
166,Progressive supranuclear palsy,0.0004393364318997317,22.60340909090909,174.7298918871199,GRN;TREM2;APOE,0.0057748921349711725,DisGeNET,GRN;TREM2;APOE,,,3,0,0
167,Recurrent hepatitis,0.00046573681352710507,74.83677298311444,574.139479895918,APOE;HLA-DRB1,0.006013240988852918,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
168,Complex Regional Pain Syndromes,0.00046573681352710507,74.83677298311444,574.139479895918,HLA-DRB1;HLA-DQB1,0.006013240988852918,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
169,Perseveration,0.00046573681352710507,74.83677298311444,574.139479895918,GRN;TREM2,0.006013240988852918,DisGeNET,GRN;TREM2,,,2,0,0
170,"Tuberculosis, Pulmonary",0.0004695726308822086,12.302719502719503,94.28419856606095,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.0060271028269704655,DisGeNET,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQA1;HLA-DQB1,4,4,4
55,Sarcoidosis,0.0004041897176269234,81.07723577235772,633.5072130174765,BTNL2;HLA-DQB1,0.006070063437932903,GWAS_Catalog_2023,BTNL2;HLA-DQB1,BTNL2;HLA-DQB1,BTNL2;HLA-DQB1,2,2,2
56,Blood Sugar Levels,0.0004041897176269234,81.07723577235772,633.5072130174765,KCNQ1;IGF2BP2,0.006070063437932903,GWAS_Catalog_2023,,KCNQ1;IGF2BP2,,0,2,0
171,Rhabdoid Tumor,0.00047782785171347563,21.93639705882353,167.73139610325921,CDKN1C;CDKN2B;KCNQ1,0.006091086161444096,DisGeNET,,CDKN1C;CDKN2B;KCNQ1,,0,3,0
172,Complete atrioventricular block,0.0004801406140093421,12.227988878591288,93.4393400234872,KCNQ1;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.006091086161444096,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,KCNQ1;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,4,3
174,Chorea,0.0005184195970282122,21.3075,161.18539095065847,TREM2;HLA-DRB1;HLA-DQB1,0.006501100923652638,DisGeNET,TREM2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
173,Guillain-Barre Syndrome,0.0005184195970282122,21.3075,161.18539095065847,APOE;HLA-DRB1;HLA-DQB1,0.006501100923652638,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
175,Celiac Disease,0.000529800881623874,8.421909823418481,63.526544265471834,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.006552717365101217,DisGeNET,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,5,5,5
176,Achalasia,0.0005315449008354333,69.48780487804878,523.9187926178153,HLA-DQA1;HLA-DQB1,0.006552717365101217,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
177,Neurofibrillary degeneration (morphologic abnormality),0.0005315449008354333,69.48780487804878,523.9187926178153,TREM2;APOE,0.006552717365101217,DisGeNET,TREM2;APOE,,,2,0,0
178,Uveomeningoencephalitic Syndrome,0.0005395177057599866,21.006338028169015,158.06922667033186,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.006613638393080284,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
179,Mucosa-Associated Lymphoid Tissue Lymphoma,0.0005471451300707842,11.797853309481216,88.61127499841832,CDKN1C;BTNL2;HLA-DQA1;HLA-DQB1,0.006669668568795816,DisGeNET,BTNL2;HLA-DQA1;HLA-DQB1,CDKN1C;BTNL2;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DQA1;HLA-DQB1,3,4,3
27,Collagen disease,0.0013126515814769549,42.27783669141039,280.54329796205764,HLA-DQB2;HLA-DQB1,0.006854958258824098,Jensen_DISEASES,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,2,2,2
57,Psoriasis Or Type 2 Diabetes (Trans-Disease Meta-Analysis),0.00046573681352710507,74.83677298311444,574.139479895918,CCND2;JAZF1,0.006871660704847287,GWAS_Catalog_2023,JAZF1,CCND2;JAZF1,JAZF1,1,2,1
180,Hyperglycemia,0.0005799133916465143,6.552091510597735,48.83032548497465,MTNR1B;GIPR;IGF2BP2;APOE;HLA-DRB1;APPL1,0.006993756673162802,DisGeNET,GIPR;APOE;HLA-DRB1;APPL1,MTNR1B;GIPR;IGF2BP2;HLA-DRB1,GIPR;HLA-DRB1,4,4,2
182,Acromegaly,0.0005833472568815902,20.42876712328767,152.12747032552738,CDKN2B;GIPR;APOE,0.006993756673162802,DisGeNET,GIPR;APOE,CDKN2B;GIPR,GIPR,2,2,1
181,Glioblastoma,0.0005809597658814701,3.626041055718475,27.017012046347645,CDKN1C;CDKN2B;GRN;CCND2;IDUA;SLC22A18;CHST15;HLA-DRA;TREM2;IGF2BP2;APOE;HLA-DRB1,0.006993756673162802,DisGeNET,GRN;IDUA;HLA-DRA;TREM2;APOE;HLA-DRB1,CDKN1C;CDKN2B;CCND2;SLC22A18;CHST15;HLA-DRA;IGF2BP2;HLA-DRB1,HLA-DRA;HLA-DRB1,6,8,2
184,Familial Dementia,0.0006015962324961352,64.85203252032521,480.9377475175773,GRN;TREM2,0.007057435372615952,DisGeNET,GRN;TREM2,,,2,0,0
185,Fragmented sleep,0.0006015962324961352,64.85203252032521,480.9377475175773,HLA-DRB1;HLA-DQB1,0.007057435372615952,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
186,Lofgrens syndrome,0.0006015962324961352,64.85203252032521,480.9377475175773,BTNL2;HLA-DRB1,0.007057435372615952,DisGeNET,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,2,2,2
183,Erythema Multiforme,0.0006015962324961352,64.85203252032521,480.9377475175773,HLA-DQB2;HLA-DQB1,0.007057435372615952,DisGeNET,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,2,2,2
187,insulinoma,0.0006078628697954807,11.461683326090105,84.88019783684098,CDKN1C;CDKN2B;CCND2;HLA-DQB1,0.007092817015474539,DisGeNET,HLA-DQB1,CDKN1C;CDKN2B;CCND2;HLA-DQB1,HLA-DQB1,1,4,1
60,Venous Thromboembolism Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy),0.0005315449008354333,69.48780487804878,523.9187926178153,TSPAN15;PLCG2,0.007450487693376657,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
59,Childhood Steroid-Sensitive Nephrotic Syndrome,0.0005315449008354333,69.48780487804878,523.9187926178153,BTNL2;HLA-DQB1,0.007450487693376657,GWAS_Catalog_2023,BTNL2;HLA-DQB1,BTNL2;HLA-DQB1,BTNL2;HLA-DQB1,2,2,2
58,Body Mass Index,0.000516328204963962,3.6788455008488965,27.844327877700252,CCND2;GIPR;ZC3H4;QPCTL;KCNQ1;JADE2;IGF2BP2;APOE;NPAS1;EML2;HLA-DRB1;JAZF1,0.007450487693376657,GWAS_Catalog_2023,GIPR;ZC3H4;QPCTL;APOE;NPAS1;EML2;HLA-DRB1;JAZF1,CCND2;GIPR;ZC3H4;QPCTL;KCNQ1;JADE2;IGF2BP2;NPAS1;EML2;HLA-DRB1;JAZF1,GIPR;ZC3H4;QPCTL;NPAS1;EML2;HLA-DRB1;JAZF1,8,11,7
61,LDL Cholesterol Levels,0.0005453851745755094,8.366547436552546,62.86639029997533,QPCTL;HLA-DRA;APOE;HLA-DRB1;HLA-DQA1,0.007519162816688582,GWAS_Catalog_2023,QPCTL;HLA-DRA;APOE;HLA-DRB1;HLA-DQA1,QPCTL;HLA-DRA;HLA-DRB1;HLA-DQA1,QPCTL;HLA-DRA;HLA-DRB1;HLA-DQA1,5,4,4
63,Birth Weight,0.0005830293250192724,11.593846153846155,86.34253827026593,CCND2;MTNR1B;KCNQ1;IGF2BP3,0.007665547547459646,GWAS_Catalog_2023,,CCND2;MTNR1B;KCNQ1;IGF2BP3,,0,4,0
62,Neutrophil Count,0.0005698810705617067,5.563015166501813,41.556184284386035,TSPAN15;TOX2;IGF2BP3;JADE2;HLA-DQA2;HLA-DQA1;HLA-DQB1,0.007665547547459646,GWAS_Catalog_2023,HLA-DQA2;HLA-DQA1;HLA-DQB1,TSPAN15;TOX2;IGF2BP3;JADE2;HLA-DQA2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DQA1;HLA-DQB1,3,7,3
64,Direct Bilirubin Levels,0.0005833472568815902,20.42876712328767,152.12747032552738,SLC22A18;APOE;JAZF1,0.007665547547459646,GWAS_Catalog_2023,APOE;JAZF1,SLC22A18;JAZF1,JAZF1,2,2,1
28,Addison's disease,0.0015316216181504704,38.89170731707317,252.0738094731918,HLA-DQA1;HLA-DRB1,0.007712808862829154,Jensen_DISEASES,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
191,Primary Progressive Aphasia (disorder),0.0006758731147824064,60.795731707317074,443.7787597089313,GRN;APOE,0.007721231080917334,DisGeNET,GRN;APOE,,,2,0,0
188,Smith-Lemli-Opitz Syndrome,0.0006758731147824064,60.795731707317074,443.7787597089313,SLC22A18;APOE,0.007721231080917334,DisGeNET,APOE,SLC22A18,,1,1,0
189,Primary antiphospholipid syndrome,0.0006758731147824064,60.795731707317074,443.7787597089313,HLA-DRB1;HLA-DQB1,0.007721231080917334,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
190,Primary cutaneous B-cell lymphoma,0.0006758731147824064,60.795731707317074,443.7787597089313,CDKN2B;IGF2BP3,0.007721231080917334,DisGeNET,,CDKN2B;IGF2BP3,,0,2,0
192,Familial Alzheimer Disease (FAD),0.0007007151246070292,11.021739130434783,80.05540071471528,PLCG2;TREM2;APOE;PICALM,0.007963335426523634,DisGeNET,PLCG2;TREM2;APOE;PICALM,,,4,0,0
193,Alzheimer's Disease,0.0007146962692512135,3.5343703946291143,25.601752372063284,GRN;APH1B;IDUA;KCNQ1;PLCG2;HLA-DRA;TREM2;BTNL2;APOE;HLA-DRB1;PICALM;APPL1,0.008080141240964496,DisGeNET,GRN;APH1B;IDUA;PLCG2;HLA-DRA;TREM2;BTNL2;APOE;HLA-DRB1;PICALM;APPL1,KCNQ1;HLA-DRA;BTNL2;HLA-DRB1,HLA-DRA;BTNL2;HLA-DRB1,11,4,3
65,Asthma (Childhood Onset),0.0006334395984132004,11.332473857613522,83.45625748745468,HLA-DQA2;HLA-DQA1;HLA-DQB1;JAZF1,0.008195733881007715,GWAS_Catalog_2023,HLA-DQA2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DQA2;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DQA2;HLA-DQA1;HLA-DQB1;JAZF1,4,4,4
194,Graves Disease,0.0007306802009089565,7.825757575757576,56.513979696127414,BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.008218269063831664,DisGeNET,BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,BTNL2;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,5
195,"Aneurysm, Dissecting",0.0007543579072186544,57.21664275466284,411.3672708004445,CDKN2B;APOE,0.008314673651429249,DisGeNET,APOE,CDKN2B,,1,1,0
197,Pulmonary Infiltrate,0.0007543579072186544,57.21664275466284,411.3672708004445,APOE;HLA-DRB1,0.008314673651429249,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
198,Maturity onset diabetes mellitus in young,0.0007544937593872554,18.6346875,133.97340656516064,MTNR1B;NEUROG3;APPL1,0.008314673651429249,DisGeNET,APPL1,MTNR1B;NEUROG3,,1,2,0
196,Mixed Connective Tissue Disease,0.0007543579072186544,57.21664275466284,411.3672708004445,HLA-DRB1;HLA-DQB1,0.008314673651429249,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
199,Cerebral atrophy,0.0007605751908131133,7.7540698593330175,55.68535318473843,GRN;TREM2;APOE;HLA-DRB1;PICALM,0.008339573197759867,DisGeNET,GRN;TREM2;APOE;HLA-DRB1;PICALM,HLA-DRB1,HLA-DRB1,5,1,1
66,Asthma-COPD Overlap Syndrome,0.0006758731147824064,60.795731707317074,443.7787597089313,IL17RD;HLA-DQB1,0.008612261962606118,GWAS_Catalog_2023,IL17RD;HLA-DQB1,HLA-DQB1,HLA-DQB1,2,1,1
200,Thrombocytopenia,0.0007913778790344561,7.683662280701754,54.87467969297853,CDKN1C;CDKN2B;BTNL2;APOE;HLA-DRB1,0.008633932660265917,DisGeNET,BTNL2;APOE;HLA-DRB1,CDKN1C;CDKN2B;BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,3,4,2
201,"Amnesia, Transient Global",0.0008370330222898128,54.03523035230352,382.87456973669936,HLA-DRB1;HLA-DQB1,0.008997074160770304,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
202,Vulval intraepithelial neoplasia,0.0008370330222898128,54.03523035230352,382.87456973669936,HLA-DRB1;HLA-DQB1,0.008997074160770304,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
203,Dysgraphia,0.0008370330222898128,54.03523035230352,382.87456973669936,GRN;TREM2,0.008997074160770304,DisGeNET,GRN;TREM2,,,2,0,0
30,Crohn's disease,0.0019482960977915294,8.28625472887768,51.712859211282435,BTNL2;HLA-DQA2;HLA-DQA1;JAZF1,0.009156991659620188,Jensen_DISEASES,BTNL2;HLA-DQA2;HLA-DQA1;JAZF1,BTNL2;HLA-DQA2;HLA-DQA1;JAZF1,BTNL2;HLA-DQA2;HLA-DQA1;JAZF1,4,4,4
29,Cardiovascular system disease,0.0018916885408923104,8.355583810129264,52.39189551472568,MTNR1B;APOE;PVRL2;HLA-DQB1,0.009156991659620188,Jensen_DISEASES,APOE;PVRL2;HLA-DQB1,MTNR1B;HLA-DQB1,HLA-DQB1,3,2,1
69,Idiopathic Membranous Nephropathy,0.0007543579072186544,57.21664275466284,411.3672708004445,BTNL2;HLA-DQA1,0.009194420289433163,GWAS_Catalog_2023,BTNL2;HLA-DQA1,BTNL2;HLA-DQA1,BTNL2;HLA-DQA1,2,2,2
68,Type Ii Diabetes,0.0007543579072186544,57.21664275466284,411.3672708004445,KCNQ1;IGF2BP2,0.009194420289433163,GWAS_Catalog_2023,,KCNQ1;IGF2BP2,,0,2,0
67,C-X-C Motif Chemokine 16 Levels,0.0007543579072186544,57.21664275466284,411.3672708004445,TOX2;HLA-DQA1,0.009194420289433163,GWAS_Catalog_2023,HLA-DQA1,TOX2;HLA-DQA1,HLA-DQA1,1,2,1
70,Venous Thromboembolism Or Tissue Plasminogen Activator Levels (Pleiotropy),0.0008370330222898128,54.03523035230352,382.87456973669936,TSPAN15;PLCG2,0.009777010718690731,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
71,Venous Thromboembolism Or Factor XI Levels (Pleiotropy),0.0008370330222898128,54.03523035230352,382.87456973669936,TSPAN15;PLCG2,0.009777010718690731,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
72,Sarcoidosis (Lofgren's Syndrome Vs non-Lofgren's Syndrome),0.0008370330222898128,54.03523035230352,382.87456973669936,HLA-DRA;HLA-DQA1,0.009777010718690731,GWAS_Catalog_2023,HLA-DRA;HLA-DQA1,HLA-DRA;HLA-DQA1,HLA-DRA;HLA-DQA1,2,2,2
206,Diastasis recti,0.0009238809256518343,51.18870346598203,357.6517529213759,CDKN1C;KCNQ1,0.009785962037729624,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
205,Neonatal Systemic lupus erythematosus,0.0009238809256518343,51.18870346598203,357.6517529213759,HLA-DQA1;HLA-DQB1,0.009785962037729624,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
204,Restlessness,0.0009238809256518343,51.18870346598203,357.6517529213759,GRN;TREM2,0.009785962037729624,DisGeNET,GRN;TREM2,,,2,0,0
210,Adrenal Cortical Adenoma,0.001017451521498842,16.742696629213484,115.36478575635245,CDKN1C;CDKN2B;GIPR,0.010571805809097494,DisGeNET,GIPR,CDKN1C;CDKN2B;GIPR,GIPR,1,3,1
207,Herpes zoster disease,0.001014884135775059,48.62682926829268,335.18380172445745,APOE;HLA-DRB1,0.010571805809097494,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
209,Pancolitis,0.001014884135775059,48.62682926829268,335.18380172445745,HLA-DRB1;HLA-DQB1,0.010571805809097494,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
208,Hypothalamic gonadotropin-releasing hormone deficiency,0.001014884135775059,48.62682926829268,335.18380172445745,HESX1;IL17RD,0.010571805809097494,DisGeNET,HESX1;IL17RD,,,2,0,0
211,Presenile dementia,0.0010338962260585923,7.223942208462332,49.66041907847833,GRN;PLCG2;TREM2;APOE;PICALM,0.010691760972795492,DisGeNET,GRN;PLCG2;TREM2;APOE;PICALM,,,5,0,0
212,Metabolic Syndrome X,0.0010604541550718932,5.808816196270071,39.78491912344245,GRN;MTNR1B;GIPR;IGF2BP2;APOE;HLA-DRB1,0.010914674369655052,DisGeNET,GRN;GIPR;APOE;HLA-DRB1,MTNR1B;GIPR;IGF2BP2;HLA-DRB1,GIPR;HLA-DRB1,4,4,2
221,Petechiae,0.0011100252238666322,46.3089430894309,315.0569917577159,APOE;HLA-DRB1,0.010959615558719419,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
220,Chromosome 11p11.2 Deletion Syndrome,0.0011100252238666322,46.3089430894309,315.0569917577159,HLA-DRB1;HLA-DQB1,0.010959615558719419,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
219,Macule,0.0011100252238666322,46.3089430894309,315.0569917577159,HLA-DRB1;HLA-DQB1,0.010959615558719419,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
218,Loss of speech,0.0011100252238666322,46.3089430894309,315.0569917577159,GRN;TREM2,0.010959615558719419,DisGeNET,GRN;TREM2,,,2,0,0
216,Typhoid Fever,0.0011100252238666322,46.3089430894309,315.0569917577159,HLA-DRB1;HLA-DQB1,0.010959615558719419,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
215,Esophageal Achalasia,0.0011100252238666322,46.3089430894309,315.0569917577159,HLA-DQA1;HLA-DQB1,0.010959615558719419,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
214,Enlarged kidney,0.0011100252238666322,46.3089430894309,315.0569917577159,CDKN1C;KCNQ1,0.010959615558719419,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
213,Macroglossia,0.001082789485515373,16.373076923076923,111.7988847060665,CDKN1C;IDUA;KCNQ1,0.010959615558719419,DisGeNET,IDUA,CDKN1C;KCNQ1,,1,2,0
217,Andersen Syndrome,0.0011100252238666322,46.3089430894309,315.0569917577159,KCNQ1;APOE,0.010959615558719419,DisGeNET,APOE,KCNQ1,,1,1,0
222,Blast Phase,0.001134307320495641,9.644444444444444,65.40604816498089,CDKN1C;CDKN2B;CCND2;HLA-DRB1,0.011098917369154658,DisGeNET,HLA-DRB1,CDKN1C;CDKN2B;CCND2;HLA-DRB1,HLA-DRB1,1,4,1
223,Parkinsonian Disorders,0.001134307320495641,9.644444444444444,65.40604816498089,GRN;TREM2;APOE;HLA-DRB1,0.011098917369154658,DisGeNET,GRN;TREM2;APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,4,1,1
224,Nephroblastoma,0.0011394901155391826,7.062725306416727,47.86532102575984,CDKN1C;CCND2;KCNQ1;SLC22A18;HLA-DRB1,0.011099854607618288,DisGeNET,HLA-DRB1,CDKN1C;CCND2;KCNQ1;SLC22A18;HLA-DRB1,HLA-DRB1,1,5,1
225,Diabetic Nephropathy,0.0011963792643215003,5.668955441928415,38.14331478012957,GIPR;IDUA;KCNQ1;IGF2BP2;APOE;HLA-DRB1,0.011373550979745828,DisGeNET,GIPR;IDUA;APOE;HLA-DRB1,GIPR;KCNQ1;IGF2BP2;HLA-DRB1,GIPR;HLA-DRB1,4,4,2
227,Repeated speech,0.0012092868136118387,44.20177383592018,296.9353391905164,GRN;TREM2,0.011373550979745828,DisGeNET,GRN;TREM2,,,2,0,0
229,Generalized overgrowth,0.0012092868136118387,44.20177383592018,296.9353391905164,CDKN1C;KCNQ1,0.011373550979745828,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
228,Fetal overgrowth,0.0012092868136118387,44.20177383592018,296.9353391905164,CDKN1C;KCNQ1,0.011373550979745828,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
226,Erectile abnormalities,0.0012092868136118387,44.20177383592018,296.9353391905164,HESX1;IL17RD,0.011373550979745828,DisGeNET,HESX1;IL17RD,,,2,0,0
232,Echolalia,0.0012092868136118387,44.20177383592018,296.9353391905164,GRN;TREM2,0.011373550979745828,DisGeNET,GRN;TREM2,,,2,0,0
230,Cognitive changes,0.0012092868136118387,44.20177383592018,296.9353391905164,GRN;APOE,0.011373550979745828,DisGeNET,GRN;APOE,,,2,0,0
231,Overgrowth,0.0012092868136118387,44.20177383592018,296.9353391905164,CDKN1C;KCNQ1,0.011373550979745828,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
233,Hypercalcemia,0.0012212982724261697,15.680526315789473,105.18247463067819,CDKN1C;CDKN2B;HLA-DRB1,0.011437222448214174,DisGeNET,HLA-DRB1,CDKN1C;CDKN2B;HLA-DRB1,HLA-DRB1,1,3,1
234,Nonorganic psychosis,0.0012561939417458329,9.37369420702754,62.613172835144184,GRN;MTNR1B;APOE;NPAS1,0.011713740089270973,DisGeNET,GRN;APOE;NPAS1,MTNR1B;NPAS1,NPAS1,3,2,1
73,Offspring Birth Weight,0.001017451521498842,16.742696629213484,115.36478575635245,CCND2;MTNR1B;KCNQ1,0.011721599035349674,GWAS_Catalog_2023,,CCND2;MTNR1B;KCNQ1,,0,3,0
74,Low Density Lipoprotein Cholesterol Levels,0.0010377928539311593,5.000371857801577,34.35585029238203,CCND2;GIPR;HLA-DRA;APOE;HLA-DQA1;HLA-DQB1;JAZF1,0.011794375542650068,GWAS_Catalog_2023,GIPR;HLA-DRA;APOE;HLA-DQA1;HLA-DQB1;JAZF1,CCND2;GIPR;HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,GIPR;HLA-DRA;HLA-DQA1;HLA-DQB1;JAZF1,6,6,5
75,Lung Function (FEV1),0.0010578293776537704,9.833706746328106,67.37599802120471,ATP8B4;IGF2BP3;HLA-DQB1;JAZF1,0.011861793421424278,GWAS_Catalog_2023,ATP8B4;HLA-DQB1;JAZF1,IGF2BP3;HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,3,3,2
236,Port-Wine Stain,0.0013126515814769549,42.27783669141039,280.54329796205764,CDKN1C;KCNQ1,0.012136465045689472,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
235,Lupus anticoagulant disorder,0.0013126515814769549,42.27783669141039,280.54329796205764,HLA-DRB1;HLA-DQB1,0.012136465045689472,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
237,Cardiovascular Diseases,0.0013303948840433938,4.780591168091168,31.65841077330397,TSPAN15;CDKN2B;GIPR;KCNQ1;IGF2BP2;APOE;HLA-DRB1,0.012248614502036646,DisGeNET,GIPR;APOE;HLA-DRB1,TSPAN15;CDKN2B;GIPR;KCNQ1;IGF2BP2;HLA-DRB1,GIPR;HLA-DRB1,3,6,2
2,diabetes mellitus type 2,0.001647192500753881,37.39399624765478,239.64626637110106,MTNR1B;IGF2BP2,0.012353943755654108,ClinVar_2019,,MTNR1B;IGF2BP2,,0,2,0
76,Neutrophil-to-lymphocyte Ratio,0.001150725295437434,16.019354838709678,108.40878671592486,BTNL2;HLA-DQA1;JAZF1,0.012733683861353711,GWAS_Catalog_2023,BTNL2;HLA-DQA1;JAZF1,BTNL2;HLA-DQA1;JAZF1,BTNL2;HLA-DQA1;JAZF1,3,3,3
241,Dermatitis Herpetiformis,0.0014201022558982558,40.514227642276424,265.65286017600937,HLA-DQA1;HLA-DQB1,0.012857523329336075,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
238,Generalized pustular psoriasis,0.0014201022558982558,40.514227642276424,265.65286017600937,APOE;HLA-DRB1,0.012857523329336075,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
239,Aortic root dilatation,0.0014201022558982558,40.514227642276424,265.65286017600937,HLA-DQB2;HLA-DRB1,0.012857523329336075,DisGeNET,HLA-DQB2;HLA-DRB1,HLA-DQB2;HLA-DRB1,HLA-DQB2;HLA-DRB1,2,2,2
240,Personality change,0.0014201022558982558,40.514227642276424,265.65286017600937,GRN;TREM2,0.012857523329336075,DisGeNET,GRN;TREM2,,,2,0,0
78,Subcutaneous Adipose Tissue,0.0012092868136118387,44.20177383592018,296.9353391905164,SNRPD2;QPCTL,0.013038592439071236,GWAS_Catalog_2023,SNRPD2;QPCTL,SNRPD2;QPCTL,SNRPD2;QPCTL,2,2,2
77,Triglyceride Levels,0.0012082488405706707,4.864913805591772,32.68532819694104,CCND2;ZC3H4;KCNQ1;APOE;HLA-DQA1;HLA-DQB1;JAZF1,0.013038592439071236,GWAS_Catalog_2023,ZC3H4;APOE;HLA-DQA1;HLA-DQB1;JAZF1,CCND2;ZC3H4;KCNQ1;HLA-DQA1;HLA-DQB1;JAZF1,ZC3H4;HLA-DQA1;HLA-DQB1;JAZF1,5,6,4
242,Pick Disease of the Brain,0.0014896249030591868,14.599264705882353,95.02998543179133,GRN;TREM2;APOE,0.013431246026756799,DisGeNET,GRN;TREM2;APOE,,,3,0,0
245,Aphasia,0.0015316216181504704,38.89170731707317,252.0738094731918,GRN;APOE,0.013640809676752352,DisGeNET,GRN;APOE,,,2,0,0
244,Apathy,0.0015316216181504704,38.89170731707317,252.0738094731918,GRN;APOE,0.013640809676752352,DisGeNET,GRN;APOE,,,2,0,0
243,Generalized vitiligo,0.0015316216181504704,38.89170731707317,252.0738094731918,BTNL2;HLA-DQA1,0.013640809676752352,DisGeNET,BTNL2;HLA-DQA1,BTNL2;HLA-DQA1,BTNL2;HLA-DQA1,2,2,2
246,Rhabdomyosarcoma,0.001555683824772726,6.567199248120301,42.46246005483993,CDKN1C;CDKN2B;CCND2;SLC22A18;HLA-DRB1,0.013798789047374341,DisGeNET,HLA-DRB1,CDKN1C;CDKN2B;CCND2;SLC22A18;HLA-DRB1,HLA-DRB1,1,5,1
79,Asthma (Moderate Or Severe),0.0013126515814769549,42.27783669141039,280.54329796205764,HLA-DQA1;HLA-DQB1,0.013799249750276488,GWAS_Catalog_2023,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
80,Hepatitis B,0.0013126515814769549,42.27783669141039,280.54329796205764,HLA-DRA;HLA-DQB2,0.013799249750276488,GWAS_Catalog_2023,HLA-DRA;HLA-DQB2,HLA-DRA;HLA-DQB2,HLA-DRA;HLA-DQB2,2,2,2
247,Lymphoma,0.001577336681489445,3.8051980422369254,24.551204355169563,CDKN2B;GRN;CCND2;PLCG2;IGF2BP3;IGF2BP2;APOE;HLA-DRB1;HLA-DQA1,0.013934205016234692,DisGeNET,GRN;PLCG2;APOE;HLA-DRB1;HLA-DQA1,CDKN2B;CCND2;IGF2BP3;IGF2BP2;HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,5,6,2
248,"Plaque, Amyloid",0.0016006305971496021,8.758352758352759,56.38064872893336,GRN;MTNR1B;TREM2;APOE,0.014037274901415079,DisGeNET,GRN;TREM2;APOE,MTNR1B,,3,1,0
249,Cystic Fibrosis,0.0016018705089149196,5.341698841698841,34.38228936843787,KCNQ1;APOE;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.014037274901415079,DisGeNET,APOE;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,KCNQ1;HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DQA2;HLA-DQB2;HLA-DQA1;HLA-DQB1,5,5,4
251,Hyperinsulinemic hypoglycemia,0.001647192500753881,37.39399624765478,239.64626637110106,CDKN1C;CDKN2B,0.014150291482854209,DisGeNET,,CDKN1C;CDKN2B,,0,2,0
252,Agranulocytosis,0.001647192500753881,37.39399624765478,239.64626637110106,HLA-DRB1;HLA-DQB1,0.014150291482854209,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
250,Uveal melanoma,0.001625703298135029,8.720159151193634,55.99924672905672,CDKN2B;CCND2;MTNR1B;EML2,0.014150291482854209,DisGeNET,EML2,CDKN2B;CCND2;MTNR1B;EML2,EML2,1,4,1
253,Plasma cell dyscrasia,0.001647192500753881,37.39399624765478,239.64626637110106,CDKN2B;CCND2,0.014150291482854209,DisGeNET,,CDKN2B;CCND2,,0,2,0
254,Psoriasiform eczema,0.001647192500753881,37.39399624765478,239.64626637110106,HLA-DRB1;HLA-DQB1,0.014150291482854209,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
255,Psoriasis,0.0016610652763271816,4.5904233456637895,29.38006886478563,GRN;APOE;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.01421350758018004,DisGeNET,GRN;APOE;HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DQA2;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,7,5,5
256,"Hepatitis B, Chronic",0.0016766684128947064,8.644751260135875,55.24814317285851,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.014290978425532223,DisGeNET,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,4,4,4
83,Fasting Blood Glucose (BMI Interaction),0.0014201022558982558,40.514227642276424,265.65286017600937,MTNR1B;IGF2BP2,0.014389228882053412,GWAS_Catalog_2023,,MTNR1B;IGF2BP2,,0,2,0
82,Mental Health Study Participation (Completed Survey),0.0014201022558982558,40.514227642276424,265.65286017600937,JADE2;APOE,0.014389228882053412,GWAS_Catalog_2023,APOE,JADE2,,1,1,0
81,Parental Longevity (Mother'S Age At Death Or Mother'S Attained Age),0.0014201022558982558,40.514227642276424,265.65286017600937,APOE;JAZF1,0.014389228882053412,GWAS_Catalog_2023,APOE;JAZF1,JAZF1,JAZF1,2,1,1
257,Small testicle,0.0017022427928104391,13.913551401869158,88.71014078934452,CDKN1C;HESX1;IL17RD,0.014452504956857503,DisGeNET,HESX1;IL17RD,CDKN1C,,2,1,0
31,Frontotemporal dementia,0.0031810145747939787,26.262359920896508,151.0231473713992,GRN;TREM2,0.014468485646643582,Jensen_DISEASES,GRN;TREM2,,,2,0,0
84,Medication Use (HMG CoA Reductase Inhibitors),0.0014492243445094362,14.744554455445545,96.38112427033386,CCND2;IGF2BP2;APOE,0.014509496115862332,GWAS_Catalog_2023,APOE,CCND2;IGF2BP2,,1,2,0
258,Parkinson Disease,0.0017173289984586467,4.091125541125541,26.048135375016184,GRN;APH1B;IDUA;HLA-DRA;TREM2;APOE;HLA-DRB1;PICALM,0.014524077033475842,DisGeNET,GRN;APH1B;IDUA;HLA-DRA;TREM2;APOE;HLA-DRB1;PICALM,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,8,2,2
265,Cortical white matter abnormalities seen on MRI,0.0017667977889501455,36.00722673893406,228.23492237875305,GRN;TREM2,0.01454774632260082,DisGeNET,GRN;TREM2,,,2,0,0
264,Neonatal hypoglycemia,0.0017667977889501455,36.00722673893406,228.23492237875305,CDKN1C;KCNQ1,0.01454774632260082,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
259,"Diabetes, Autoimmune",0.0017469205497262674,13.784027777777778,87.52720800686893,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.01454774632260082,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
260,Multiple Endocrine Neoplasia Type 1,0.0017469205497262674,13.784027777777778,87.52720800686893,CDKN2B;GRN;NEUROG3,0.01454774632260082,DisGeNET,GRN,CDKN2B;NEUROG3,,1,2,0
263,Anterior hypopituitarism,0.0017667977889501455,36.00722673893406,228.23492237875305,HESX1;IL17RD,0.01454774632260082,DisGeNET,HESX1;IL17RD,,,2,0,0
262,Social disinhibition,0.0017667977889501455,36.00722673893406,228.23492237875305,GRN;TREM2,0.01454774632260082,DisGeNET,GRN;TREM2,,,2,0,0
261,Erythema Nodosum,0.0017667977889501455,36.00722673893406,228.23492237875305,BTNL2;HLA-DRB1,0.01454774632260082,DisGeNET,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,2,2,2
85,Weight,0.0015081656262016078,5.408010420058613,35.13509297927943,CCND2;GIPR;KCNQ1;JADE2;IGF2BP2;JAZF1,0.014872368000912012,GWAS_Catalog_2023,GIPR;JAZF1,CCND2;GIPR;KCNQ1;JADE2;IGF2BP2;JAZF1,GIPR;JAZF1,2,6,2
86,Body Mass Index (MTAG),0.0015370930967812757,4.656215277777778,30.162321156281493,CCND2;GIPR;ZC3H4;JADE2;APOE;EML2;JAZF1,0.014872368000912012,GWAS_Catalog_2023,GIPR;ZC3H4;APOE;EML2;JAZF1,CCND2;GIPR;ZC3H4;JADE2;EML2;JAZF1,GIPR;ZC3H4;EML2;JAZF1,5,6,4
87,Non-HDL Cholesterol Levels,0.001538520827680553,6.584331673172701,42.646280533204376,CCND2;ZC3H4;APOE;HLA-DQB1;JAZF1,0.014872368000912012,GWAS_Catalog_2023,ZC3H4;APOE;HLA-DQB1;JAZF1,CCND2;ZC3H4;HLA-DQB1;JAZF1,ZC3H4;HLA-DQB1;JAZF1,4,4,3
267,Amyloidosis,0.00184260316056414,4.503531073446328,28.356825429201223,GRN;QPCTL;SLC22A18;TREM2;APOE;HLA-DRB1;PICALM,0.01505827751442305,DisGeNET,GRN;QPCTL;TREM2;APOE;HLA-DRB1;PICALM,QPCTL;SLC22A18;HLA-DRB1,QPCTL;HLA-DRB1,6,3,2
266,Erythema,0.0018384652062925309,13.532045454545454,85.23597514715335,PLCG2;HLA-DRB1;HLA-DQB1,0.01505827751442305,DisGeNET,PLCG2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
90,Venous Thromboembolism Or Factor VII Levels (Pleiotropy),0.001647192500753881,37.39399624765478,239.64626637110106,TSPAN15;PLCG2,0.015222954869604548,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
88,Urea Levels,0.0016150547035770834,14.18,91.1545198708865,APH1B;GIPR;APOE,0.015222954869604548,GWAS_Catalog_2023,APH1B;GIPR;APOE,GIPR,GIPR,3,1,1
89,Blood Urea Nitrogen Levels,0.001625703298135029,8.720159151193634,55.99924672905672,APH1B;GIPR;APOE;HLA-DQA1,0.015222954869604548,GWAS_Catalog_2023,APH1B;GIPR;APOE;HLA-DQA1,GIPR;HLA-DQA1,GIPR;HLA-DQA1,4,2,2
91,Sj?gren's Syndrome,0.001647192500753881,37.39399624765478,239.64626637110106,HLA-DRA;HLA-DQA1,0.015222954869604548,GWAS_Catalog_2023,HLA-DRA;HLA-DQA1,HLA-DRA;HLA-DQA1,HLA-DRA;HLA-DQA1,2,2,2
268,Urticaria,0.0018853406860438778,13.409459459459459,84.12621161107936,PLCG2;HLA-DRB1;HLA-DQB1,0.015277397613422335,DisGeNET,PLCG2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
269,"Delirium, Dementia, Amnestic, Cognitive Disorders",0.0018904204196260454,34.71951219512195,217.72453437258292,TREM2;APOE,0.015277397613422335,DisGeNET,TREM2;APOE,,,2,0,0
270,Gonadoblastoma,0.0018904204196260454,34.71951219512195,217.72453437258292,CDKN1C;KCNQ1,0.015277397613422335,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
273,"Carcinoma, Granular Cell",0.0019329572618860178,13.2890625,83.03942050809016,CDKN1C;KCNQ1;APOE,0.015449497236026706,DisGeNET,APOE,CDKN1C;KCNQ1,,1,2,0
271,Splenomegaly,0.0019198473507759867,8.320776617072914,52.05069801510453,IDUA;APOE;HLA-DRB1;HLA-DQB1,0.015449497236026706,DisGeNET,IDUA;APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,2,2
272,"Carcinoma, Cribriform",0.0019329572618860178,13.2890625,83.03942050809016,CDKN1C;KCNQ1;APOE,0.015449497236026706,DisGeNET,APOE,CDKN1C;KCNQ1,,1,2,0
274,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.0019573216732023716,5.12586115527292,31.965783764492816,CDKN1C;CDKN2B;IDUA;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.015587138288056843,DisGeNET,IDUA;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN1C;CDKN2B;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,4,5,3
277,PEELING SKIN SYNDROME,0.00201804338139322,33.5206055508831,208.01637017204203,HLA-DRB1;HLA-DQB1,0.015896644975451287,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
276,Latent autoimmune diabetes mellitus in adult,0.00201804338139322,33.5206055508831,208.01637017204203,HLA-DRB1;HLA-DQB1,0.015896644975451287,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
275,Brain Diseases,0.002006069631949149,8.218052949760267,51.04707590465461,GRN;IDUA;TREM2;APOE,0.015896644975451287,DisGeNET,GRN;IDUA;TREM2;APOE,,,4,0,0
278,"Adenocarcinoma, Basal Cell",0.0020304304736449906,13.054605263157894,80.93212261743199,CDKN1C;KCNQ1;APOE,0.015936688106091258,DisGeNET,APOE,CDKN1C;KCNQ1,,1,2,0
92,Estimated Glomerular Filtration Rate (Cystatin C),0.0017469205497262674,13.784027777777778,87.52720800686893,APH1B;KCNQ1;APOE,0.01596913241651947,GWAS_Catalog_2023,APH1B;APOE,KCNQ1,,2,1,0
93,Carotid Intima Media Thickness,0.0017667977889501455,36.00722673893406,228.23492237875305,APOE;NEUROG3,0.015977171403301852,GWAS_Catalog_2023,APOE,NEUROG3,,1,1,0
279,Red Blood Cell Count measurement,0.002080295409013854,12.940434782608696,79.91036000024108,TOX2;ZC3H4;HLA-DQA1,0.01626955047479652,DisGeNET,ZC3H4;HLA-DQA1,TOX2;ZC3H4;HLA-DQA1,ZC3H4;HLA-DQA1,2,3,2
95,Apolipoprotein B Levels,0.0018499643842394518,6.304502063983488,39.67163965640283,CCND2;GIPR;HLA-DRA;APOE;HLA-DQA1,0.016377053127846094,GWAS_Catalog_2023,GIPR;HLA-DRA;APOE;HLA-DQA1,CCND2;GIPR;HLA-DRA;HLA-DQA1,GIPR;HLA-DRA;HLA-DQA1,4,4,3
94,High-density Lipoprotein Levels (MTAG),0.0018362344944614516,8.426068376068375,53.08455327400216,GIPR;ZC3H4;SLC22A18;APOE,0.016377053127846094,GWAS_Catalog_2023,GIPR;ZC3H4;APOE,GIPR;ZC3H4;SLC22A18,GIPR;ZC3H4,3,3,2
96,Venous Thromboembolism Or Factor VIII Levels (Pleiotropy),0.0018904204196260454,34.71951219512195,217.72453437258292,TSPAN15;PLCG2,0.016560870551099,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
280,Prominent metopic ridge,0.0021496497140763666,32.40162601626016,199.02537983535302,CDKN1C;KCNQ1,0.01675191312898083,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
282,Meniere Disease,0.0022852225093912054,31.35483870967742,190.6779260779712,MTNR1B;HLA-DRB1,0.017512445313642197,DisGeNET,HLA-DRB1,MTNR1B;HLA-DRB1,HLA-DRB1,1,2,1
283,Childhood T Acute Lymphoblastic Leukemia,0.0022852225093912054,31.35483870967742,190.6779260779712,CDKN2B;CCND2,0.017512445313642197,DisGeNET,,CDKN2B;CCND2,,0,2,0
284,"Adenocarcinoma, Oxyphilic",0.0022873725547149525,12.50294117647059,76.02227683860059,CDKN1C;KCNQ1;APOE,0.017512445313642197,DisGeNET,APOE,CDKN1C;KCNQ1,,1,2,0
285,Waist-Hip Ratio,0.0022873725547149525,12.50294117647059,76.02227683860059,MTNR1B;QPCTL;BTNL2,0.017512445313642197,DisGeNET,QPCTL;BTNL2,MTNR1B;QPCTL;BTNL2,QPCTL;BTNL2,2,3,2
281,Agitation,0.0022852225093912054,31.35483870967742,190.6779260779712,GRN;TREM2,0.017512445313642197,DisGeNET,GRN;TREM2,,,2,0,0
286,Endothelial dysfunction,0.0023778912835050003,7.83104750546611,47.31159613854709,MTNR1B;APOE;HLA-DRB1;APPL1,0.018141813918209477,DisGeNET,APOE;HLA-DRB1;APPL1,MTNR1B;HLA-DRB1,HLA-DRB1,3,2,1
288,Familial M??ni??re disease,0.0024507905332330584,12.193647540983607,73.30021778565637,MTNR1B;HLA-DRB1;HLA-DQA1,0.01856814216498102,DisGeNET,HLA-DRB1;HLA-DQA1,MTNR1B;HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,2,3,2
287,"Adenocarcinoma, Tubular",0.0024507905332330584,12.193647540983607,73.30021778565637,CDKN1C;KCNQ1;APOE,0.01856814216498102,DisGeNET,APOE,CDKN1C;KCNQ1,,1,2,0
289,Memory Loss,0.00250682887301696,12.09390243902439,72.42719764647528,GRN;TREM2;APOE,0.01888073041565718,DisGeNET,GRN;TREM2;APOE,,,3,0,0
290,Childhood Acute Lymphoblastic Leukemia,0.002509354638194584,5.863674597452535,35.11009839262281,CDKN1C;CDKN2B;CCND2;HLA-DRA;HLA-DRB1,0.01888073041565718,DisGeNET,HLA-DRA;HLA-DRB1,CDKN1C;CDKN2B;CCND2;HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,5,2
97,Sex Hormone-Binding Globulin Levels In Postmenopausal Women,0.002182302426567309,12.717948717948717,77.92763848903097,CCND2;IGF2BP2;JAZF1,0.018920787017970172,GWAS_Catalog_2023,JAZF1,CCND2;IGF2BP2;JAZF1,JAZF1,1,3,1
291,"Gastritis, Atrophic",0.0025636564565395072,11.995766129032258,71.57058820236952,GRN;HLA-DRB1;HLA-DQA1,0.018931799463698783,DisGeNET,GRN;HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,3,2,2
292,Excessive daytime somnolence,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DRB1;HLA-DQB1,0.018931799463698783,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
293,Sparse axillary hair,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DRA;IL17RD,0.018931799463698783,DisGeNET,HLA-DRA;IL17RD,HLA-DRA,HLA-DRA,2,1,1
294,Hepatitis B Virus-Related Hepatocellular Carcinoma,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DQA1;HLA-DQB1,0.018931799463698783,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
295,Intrahepatic Cholestasis,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DRB1;HLA-DQB1,0.018931799463698783,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
296,Low Grade Squamous Intraepithelial Neoplasia,0.002568200110565921,29.45158906134516,175.66547469692333,HLA-DRB1;HLA-DQB1,0.018931799463698783,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
299,Biliary Tract Cancer,0.002621277075775762,11.8992,70.72995911800506,CDKN2B;CCND2;IGF2BP3,0.01912918588408934,DisGeNET,,CDKN2B;CCND2;IGF2BP3,,0,3,0
297,Colorectal Cancer,0.0026153057024511372,2.7208346024977157,16.17910091369031,CDKN1C;CDKN2B;GRN;EML2;CCND2;KCNQ1;SLC22A18;HLA-DRA;IGF2BP3;ALPK2;IGF2BP2;APOE;HLA-DRB1;APPL1;JAZF1,0.01912918588408934,DisGeNET,GRN;EML2;HLA-DRA;ALPK2;APOE;HLA-DRB1;APPL1;JAZF1,CDKN1C;CDKN2B;EML2;CCND2;KCNQ1;SLC22A18;HLA-DRA;IGF2BP3;IGF2BP2;HLA-DRB1;JAZF1,EML2;HLA-DRA;HLA-DRB1;JAZF1,8,11,4
298,Arthralgia,0.002621277075775762,11.8992,70.72995911800506,PLCG2;TREM2;HLA-DRB1,0.01912918588408934,DisGeNET,PLCG2;TREM2;HLA-DRB1,HLA-DRB1,HLA-DRB1,3,1,1
300,"Hepatitis, Autoimmune",0.002679694489174682,11.804166666666667,69.90489457160028,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.019490311251263853,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
303,Autoimmune state,0.002715571355744258,28.58393113342898,168.89538608185973,HLA-DRB1;HLA-DQB1,0.019491370717874903,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
302,Low Tension Glaucoma,0.002715571355744258,28.58393113342898,168.89538608185973,CDKN2B;APOE,0.019491370717874903,DisGeNET,APOE,CDKN2B,,1,1,0
301,Thickened nuchal skin fold,0.002715571355744258,28.58393113342898,168.89538608185973,GRN;TREM2,0.019491370717874903,DisGeNET,GRN;TREM2,,,2,0,0
304,Oestrogen deficiency,0.002715571355744258,28.58393113342898,168.89538608185973,PLCG2;APOE,0.019491370717874903,DisGeNET,PLCG2;APOE,,,2,0,0
98,Venous Thromboembolism Or Von Willebrand Factor Levels (Pleiotropy),0.0022852225093912054,31.35483870967742,190.6779260779712,TSPAN15;PLCG2,0.019610940106102075,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
307,Congenital hypoplasia of breast,0.002866841941964989,27.765853658536585,162.55641815307325,HESX1;IL17RD,0.020376055756897736,DisGeNET,HESX1;IL17RD,,,2,0,0
306,Increased calcium level in kidney,0.002866841941964989,27.765853658536585,162.55641815307325,CDKN1C;KCNQ1,0.020376055756897736,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
305,Adenocarcinoma,0.002862567080424187,3.2501869458391197,19.03321330919581,CDKN1C;CDKN2B;SHARPIN;CCND2;KCNQ1;SLC22A18;IGF2BP3;APOE;HLA-DQA1;HLA-DQB1,0.020376055756897736,DisGeNET,SHARPIN;APOE;HLA-DQA1;HLA-DQB1,CDKN1C;CDKN2B;CCND2;KCNQ1;SLC22A18;IGF2BP3;HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,4,8,2
308,beta Thalassemia,0.002921406105638229,11.438653846153846,66.75244055817723,APOE;HLA-DQA1;HLA-DQB1,0.02069645494319031,DisGeNET,APOE;HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,3,2,2
309,Common acute lymphoblastic leukemia,0.0030219952153155262,26.993224932249323,156.61031811173902,HLA-DQA1;HLA-DQB1,0.021071708018668457,DisGeNET,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
310,Prominent back of the head,0.0030219952153155262,26.993224932249323,156.61031811173902,CDKN1C;KCNQ1,0.021071708018668457,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
311,Prominent occiput,0.0030219952153155262,26.993224932249323,156.61031811173902,CDKN1C;KCNQ1,0.021071708018668457,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
312,End Stage Liver Disease,0.0030219952153155262,26.993224932249323,156.61031811173902,HLA-DRB1;HLA-DQB1,0.021071708018668457,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
313,Malignant neoplasm of ovary,0.003022660224492771,3.0608250620347395,17.75773767158818,CDKN1C;CDKN2B;GRN;CCND2;CHST15;IGF2BP3;IGF2BP2;APOE;HLA-DRB1;APPL1;JAZF1,0.021071708018668457,DisGeNET,GRN;APOE;HLA-DRB1;APPL1;JAZF1,CDKN1C;CDKN2B;CCND2;CHST15;IGF2BP3;IGF2BP2;HLA-DRB1;JAZF1,HLA-DRB1;JAZF1,5,8,2
314,Motor Neuron Disease,0.0030471379886528576,11.264204545454545,65.25976032911598,GRN;TREM2;APOE,0.021107476480128683,DisGeNET,GRN;TREM2;APOE,,,3,0,0
315,Dystonia Disorders,0.0030471379886528576,11.264204545454545,65.25976032911598,APOE;HLA-DRB1;HLA-DQB1,0.021107476480128683,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
316,Crohn Disease,0.0030693280356545137,4.093431553100062,23.68580916905406,HLA-DRA;BTNL2;APOE;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,0.0211939043474625,DisGeNET,HLA-DRA;BTNL2;APOE;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,HLA-DRA;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,7,6,6
317,Coronary heart disease,0.0030881051821298063,4.088698798135884,23.633486922167613,CDKN2B;KCNQ1;IGF2BP2;APOE;HLA-DRB1;HLA-DQB1;JAZF1,0.021256294976048067,DisGeNET,APOE;HLA-DRB1;HLA-DQB1;JAZF1,CDKN2B;KCNQ1;IGF2BP2;HLA-DRB1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQB1;JAZF1,4,6,3
318,"Amyotrophic Lateral Sclerosis, Sporadic",0.0031112354458513506,11.178947368421053,64.53310500947813,GRN;TREM2;APOE,0.02134816271335738,DisGeNET,GRN;TREM2;APOE,,,3,0,0
320,Low Grade Lymphoma (neoplasm),0.0031810145747939787,26.262359920896508,151.0231473713992,CDKN1C;HLA-DRB1,0.02169054313187644,DisGeNET,HLA-DRB1,CDKN1C;HLA-DRB1,HLA-DRB1,1,2,1
319,Fasting blood glucose measurement,0.0031810145747939787,26.262359920896508,151.0231473713992,MTNR1B;IGF2BP2,0.02169054313187644,DisGeNET,,MTNR1B;IGF2BP2,,0,2,0
99,Neurofibrillary Tangles,0.002568200110565921,29.45158906134516,175.66547469692333,APOE;HLA-DRB1,0.021816730232181208,GWAS_Catalog_2023,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
322,Sparse pubic hair,0.003343883466309401,25.569961489088573,145.76469607458566,HLA-DRA;IL17RD,0.02231300832870677,DisGeNET,HLA-DRA;IL17RD,HLA-DRA,HLA-DRA,2,1,1
321,"Dermatomyositis, Childhood Type",0.003343883466309401,25.569961489088573,145.76469607458566,HLA-DQA1;HLA-DRB1,0.02231300832870677,DisGeNET,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,HLA-DQA1;HLA-DRB1,2,2,2
323,"Purpura, Thrombotic Thrombocytopenic",0.003343883466309401,25.569961489088573,145.76469607458566,HLA-DRB1;HLA-DQB1,0.02231300832870677,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
325,Malignant neoplasm of stomach stage IV,0.003343883466309401,25.569961489088573,145.76469607458566,KCNQ1;IGF2BP2,0.02231300832870677,DisGeNET,,KCNQ1;IGF2BP2,,0,2,0
326,Congenital omphalocele,0.003343883466309401,25.569961489088573,145.76469607458566,CDKN1C;KCNQ1,0.02231300832870677,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
327,Psychiatric symptom,0.003343883466309401,25.569961489088573,145.76469607458566,TREM2;APOE,0.02231300832870677,DisGeNET,TREM2;APOE,,,2,0,0
324,Islet Cell Tumor,0.003343883466309401,25.569961489088573,145.76469607458566,GRN;NEUROG3,0.02231300832870677,DisGeNET,GRN,NEUROG3,,1,1,0
328,"Cholangitis, Sclerosing",0.0033759166298489595,10.85036496350365,61.75038615247198,HLA-DRB1;NEUROG3;JAZF1,0.02245807953149521,DisGeNET,HLA-DRB1;JAZF1,HLA-DRB1;NEUROG3;JAZF1,HLA-DRB1;JAZF1,2,3,2
100,Free Cholesterol To Total Lipids Ratio In Large VLDL,0.002715571355744258,28.58393113342898,168.89538608185973,APOE;HLA-DQB1,0.022837955101809207,GWAS_Catalog_2023,APOE;HLA-DQB1,HLA-DQB1,HLA-DQB1,2,1,1
331,Dysphasia,0.003510585390397297,24.91307066916823,140.8079897526317,GRN;TREM2,0.02314228798141058,DisGeNET,GRN;TREM2,,,2,0,0
330,"Nephrotic Syndrome, Minimal Change",0.003510585390397297,24.91307066916823,140.8079897526317,APOE;HLA-DRB1,0.02314228798141058,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
329,Schwartz-Jampel Syndrome,0.003510585390397297,24.91307066916823,140.8079897526317,HLA-DRB1;HLA-DQB1,0.02314228798141058,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
332,Myositis,0.0035832287206006993,10.61625,59.78531641106525,APOE;HLA-DRB1;HLA-DQA1,0.02350431187941442,DisGeNET,APOE;HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,3,2,2
333,ovarian neoplasm,0.003587046680038956,3.973684210526316,22.373535160359225,CDKN1C;CDKN2B;GRN;CCND2;APOE;HLA-DRB1;HLA-DQA1,0.02350431187941442,DisGeNET,GRN;APOE;HLA-DRB1;HLA-DQA1,CDKN1C;CDKN2B;CCND2;HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,4,5,2
101,BMI In Non-Smokers,0.002866841941964989,27.765853658536585,162.55641815307325,ZC3H4;QPCTL,0.023871426467253026,GWAS_Catalog_2023,ZC3H4;QPCTL,ZC3H4;QPCTL,ZC3H4;QPCTL,2,2,2
334,"Mitral regurgitation, mild",0.003681103895283636,24.289024390243902,136.12887191337333,CCND2;IDUA,0.024048409279966747,DisGeNET,IDUA,CCND2,,1,1,0
102,Phospholipids To Total Lipids Ratio In Very Large VLDL,0.0030219952153155262,26.993224932249323,156.61031811173902,APOE;HLA-DQB1,0.02491664682431723,GWAS_Catalog_2023,APOE;HLA-DQB1,HLA-DQB1,HLA-DQB1,2,1,1
103,Free Cholesterol Levels In Medium LDL,0.0031810145747939787,26.262359920896508,151.0231473713992,APOE;HLA-DQA1,0.025973138421376076,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
338,Neurocognitive Disorders,0.004033525091037281,23.130081300813007,127.51878829292204,TREM2;APOE,0.02603891049894481,DisGeNET,TREM2;APOE,,,2,0,0
337,Birth Weight,0.004033525091037281,23.130081300813007,127.51878829292204,MTNR1B;IGF2BP3,0.02603891049894481,DisGeNET,,MTNR1B;IGF2BP3,,0,2,0
336,Toxic Shock Syndrome,0.004033525091037281,23.130081300813007,127.51878829292204,HLA-DRA;HLA-DRB1,0.02603891049894481,DisGeNET,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,HLA-DRA;HLA-DRB1,2,2,2
335,Sickle Cell Trait,0.004033525091037281,23.130081300813007,127.51878829292204,APOE;IL17RD,0.02603891049894481,DisGeNET,APOE;IL17RD,,,2,0,0
106,Concentration Of Small HDL Particles,0.003343883466309401,25.569961489088573,145.76469607458566,CCND2;HLA-DRB1,0.02653024523741704,GWAS_Catalog_2023,HLA-DRB1,CCND2;HLA-DRB1,HLA-DRB1,1,2,1
105,Ocular Sarcoidosis,0.003343883466309401,25.569961489088573,145.76469607458566,HLA-DQA1;HLA-DQB1,0.02653024523741704,GWAS_Catalog_2023,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,HLA-DQA1;HLA-DQB1,2,2,2
104,Hippocampal Volume,0.003343883466309401,25.569961489088573,145.76469607458566,SHARPIN;APOE,0.02653024523741704,GWAS_Catalog_2023,SHARPIN;APOE,,,2,0,0
339,Primary Sj??gren's syndrome,0.004173663308685989,10.038344594594594,54.99969991889258,APOE;HLA-DRB1;HLA-DQB1,0.02686411014617354,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
341,"Obesity, Visceral",0.004215395129783775,22.59103800340329,123.55065676287644,GRN;APOE,0.026888375604930785,DisGeNET,GRN;APOE,,,2,0,0
342,Hypopituitarism,0.004215395129783775,22.59103800340329,123.55065676287644,HESX1;APOE,0.026888375604930785,DisGeNET,HESX1;APOE,,,2,0,0
343,Infection caused by Helicobacter pylori,0.004243652573133693,6.630566801619433,36.21835008844818,CDKN1C;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.026888375604930785,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN1C;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,4,3
344,Aneurysm,0.00425137011168704,9.970469798657717,54.4438896108531,CDKN2B;HESX1;APOE,0.026888375604930785,DisGeNET,HESX1;APOE,CDKN2B,,2,1,0
345,Decreased platelet count,0.00425137011168704,9.970469798657717,54.4438896108531,BTNL2;APOE;HLA-DRB1,0.026888375604930785,DisGeNET,BTNL2;APOE;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,3,2,2
340,Sleeplessness,0.004215395129783775,22.59103800340329,123.55065676287644,HLA-DRB1;HLA-DQB1,0.026888375604930785,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
107,FEV1,0.003444176857695517,10.771195652173914,61.084208203667956,IGF2BP2;HLA-DQB1;JAZF1,0.02707058633011149,GWAS_Catalog_2023,HLA-DQB1;JAZF1,IGF2BP2;HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,2,3,2
108,Type 2 Diabetes Or Prostate Cancer (Pleiotropy),0.003510585390397297,24.91307066916823,140.8079897526317,CDKN2B;JAZF1,0.027086259755267218,GWAS_Catalog_2023,JAZF1,CDKN2B;JAZF1,JAZF1,1,2,1
109,Total Lipid Levels In Large LDL,0.003510585390397297,24.91307066916823,140.8079897526317,APOE;HLA-DQA1,0.027086259755267218,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
346,Familial lichen amyloidosis,0.004329954319218911,9.9035,53.89681073389184,GRN;APOE;PICALM,0.027281300801930464,DisGeNET,GRN;APOE;PICALM,,,3,0,0
348,"Sarcoidosis, Pulmonary",0.004401016444674392,22.07649667405765,119.78529941576386,HLA-DRB1;HLA-DQB1,0.027281300801930464,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
349,"Sleep Apnea, Central",0.004401016444674392,22.07649667405765,119.78529941576386,APOE;HLA-DRB1,0.027281300801930464,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
350,Infiltrating Cervical Carcinoma,0.004401016444674392,22.07649667405765,119.78529941576386,HLA-DQB2;HLA-DQB1,0.027281300801930464,DisGeNET,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,2,2,2
351,Moyamoya disease 1,0.004401016444674392,22.07649667405765,119.78529941576386,APOE;JAZF1,0.027281300801930464,DisGeNET,APOE;JAZF1,JAZF1,JAZF1,2,1,1
347,"Kidney Failure, Acute",0.004342044383891917,6.586559410088822,35.8269970258904,CDKN2B;GRN;APOE;HLA-DRB1,0.027281300801930464,DisGeNET,GRN;APOE;HLA-DRB1,CDKN2B;HLA-DRB1,HLA-DRB1,3,2,1
352,Decreased fertility,0.004401016444674392,22.07649667405765,119.78529941576386,HESX1;IL17RD,0.027281300801930464,DisGeNET,HESX1;IL17RD,,,2,0,0
353,Aplastic Anemia,0.0044897668135540645,9.772203947368421,52.828090033158816,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.02775260959539651,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
110,Free Cholesterol Levels In LDL,0.003681103895283636,24.289024390243902,136.12887191337333,APOE;HLA-DQA1,0.027890165548950793,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
111,Free Cholesterol Levels In Small LDL,0.003681103895283636,24.289024390243902,136.12887191337333,APOE;HLA-DQA1,0.027890165548950793,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
354,Body Height,0.00454344522626694,6.500248138957816,35.06279149182547,CCND2;KCNQ1;IGF2BP3;JAZF1,0.02800507763761148,DisGeNET,JAZF1,CCND2;KCNQ1;IGF2BP3;JAZF1,JAZF1,1,4,1
355,Mitral Valve Insufficiency,0.004590372832968766,21.584823848238482,116.20824579394697,CCND2;IDUA,0.028135375060499568,DisGeNET,IDUA,CCND2,,1,1,0
356,Carcinoma in situ of uterine cervix,0.004590372832968766,21.584823848238482,116.20824579394697,HLA-DQB2;HLA-DQB1,0.028135375060499568,DisGeNET,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,HLA-DQB2;HLA-DQB1,2,2,2
112,Platelet Count,0.003825252034737163,3.925011795234725,21.847129524397076,ATP8B4;KCNQ1;PLCG2;IGF2BP2;APOE;PICALM;HLA-DQB1,0.028442196393125462,GWAS_Catalog_2023,ATP8B4;PLCG2;APOE;PICALM;HLA-DQB1,KCNQ1;IGF2BP2;HLA-DQB1,HLA-DQB1,5,3,1
114,Cholesterol Levels In Large LDL,0.0038554225788541055,23.695419393218323,131.70564916179435,APOE;HLA-DQA1,0.028442196393125462,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
113,Cholesterol Levels In Very Small VLDL,0.0038554225788541055,23.695419393218323,131.70564916179435,APOE;HLA-DQA1,0.028442196393125462,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
357,Psychotic Disorders,0.004698579911177822,6.4369623986237405,34.50530451149253,GRN;MTNR1B;APOE;NPAS1,0.028717930997731112,DisGeNET,GRN;APOE;NPAS1,MTNR1B;NPAS1,NPAS1,3,2,1
115,Triglycerides To Total Lipids Ratio In Large VLDL,0.004033525091037281,23.130081300813007,127.51878829292204,APOE;HLA-DQA1,0.029243056910020285,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
116,Cerebrospinal Fluid Biomarker Levels,0.004033525091037281,23.130081300813007,127.51878829292204,APOE;IL17RD,0.029243056910020285,GWAS_Catalog_2023,APOE;IL17RD,,,2,0,0
359,Cardiomegaly,0.004820049529951936,9.519711538461538,50.787385700500494,CDKN1C;CCND2;KCNQ1,0.029296234190404245,DisGeNET,,CDKN1C;CCND2;KCNQ1,,0,3,0
358,Malignant neoplasm of large intestine,0.004809793854085136,5.007209805335256,26.723984727458,CDKN1C;CDKN2B;GRN;KCNQ1;ALPK2,0.029296234190404245,DisGeNET,GRN;ALPK2,CDKN1C;CDKN2B;KCNQ1,,2,3,0
119,Calcium Levels,0.004243652573133693,6.630566801619433,36.21835008844818,TOX2;CCND2;SLC22A18;JADE2,0.02999085557987761,GWAS_Catalog_2023,,TOX2;CCND2;SLC22A18;JADE2,,0,4,0
118,Waist Circumference Adjusted For Body Mass Index,0.004217035970031896,3.8519870235198703,21.06506396384544,CCND2;KCNQ1;HLA-DRA;IGF2BP3;BTNL2;IGF2BP2;JAZF1,0.02999085557987761,GWAS_Catalog_2023,HLA-DRA;BTNL2;JAZF1,CCND2;KCNQ1;HLA-DRA;IGF2BP3;BTNL2;IGF2BP2;JAZF1,HLA-DRA;BTNL2;JAZF1,3,7,3
117,BMI (Standard GWA),0.004173663308685989,10.038344594594594,54.99969991889258,GIPR;JADE2;NPAS1,0.02999085557987761,GWAS_Catalog_2023,GIPR;NPAS1,GIPR;JADE2;NPAS1,GIPR;NPAS1,2,3,2
361,Weight decreased,0.004990565217077276,9.398259493670887,49.81271235109973,BTNL2;HLA-DRB1;HLA-DQB1,0.030164579788539102,DisGeNET,BTNL2;HLA-DRB1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQB1,BTNL2;HLA-DRB1;HLA-DQB1,3,3,3
360,Abnormality of vision,0.004980226270684628,20.664244940321744,109.56761169296043,HLA-DRB1;HLA-DQB1,0.030164579788539102,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
120,Cholesterol To Total Lipids Ratio In Small HDL,0.004401016444674392,22.07649667405765,119.78529941576386,GIPR;APOE,0.0308437902497597,GWAS_Catalog_2023,GIPR;APOE,GIPR,GIPR,2,1,1
362,Varicella zoster,0.005180691162792406,20.232723577235774,106.48111760263689,APOE;HLA-DRB1,0.031055681640695134,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
363,Advanced bone age,0.005180691162792406,20.232723577235774,106.48111760263689,CDKN1C;KCNQ1,0.031055681640695134,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
364,Moyamoya Disease,0.005180691162792406,20.232723577235774,106.48111760263689,APOE;JAZF1,0.031055681640695134,DisGeNET,APOE;JAZF1,JAZF1,JAZF1,2,1,1
122,Venous Thromboembolism Or Fibrinogen Levels (Pleiotropy),0.004590372832968766,21.584823848238482,116.20824579394697,TSPAN15;PLCG2,0.03105775774856803,GWAS_Catalog_2023,PLCG2,TSPAN15,,1,1,0
124,Pulse Pressure,0.004615171336138523,4.277166054943833,23.004336795288783,ATP8B4;CCND2;MTNR1B;GIPR;QPCTL;APOE,0.03105775774856803,GWAS_Catalog_2023,ATP8B4;GIPR;QPCTL;APOE,CCND2;MTNR1B;GIPR;QPCTL,GIPR;QPCTL,4,4,2
125,Lymphocyte Count,0.004645697125970472,4.27108478341355,22.943472338696758,CCND2;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,0.03105775774856803,GWAS_Catalog_2023,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,CCND2;BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,BTNL2;HLA-DRB1;HLA-DQB2;HLA-DQB1;JAZF1,5,6,5
126,Peak Expiratory Flow,0.004653124228679633,9.644318181818182,51.79207574258261,IGF2BP2;HLA-DQB1;JAZF1,0.03105775774856803,GWAS_Catalog_2023,HLA-DQB1;JAZF1,IGF2BP2;HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,2,3,2
121,Estimated Glomerular Filtration Rate (Creatinine),0.004584794865183838,4.283264033264033,23.065419286372652,APH1B;GIPR;KCNQ1;SLC22A18;APOE;IL17RD,0.03105775774856803,GWAS_Catalog_2023,APH1B;GIPR;APOE;IL17RD,GIPR;KCNQ1;SLC22A18,GIPR,4,3,1
123,Age At First Birth,0.004590372832968766,21.584823848238482,116.20824579394697,JADE2;HLA-DQA2,0.03105775774856803,GWAS_Catalog_2023,HLA-DQA2,JADE2;HLA-DQA2,HLA-DQA2,1,2,1
127,Body Surface Area,0.004698579911177822,6.4369623986237405,34.50530451149253,GIPR;ZC3H4;IGF2BP2;JAZF1,0.03111421815197282,GWAS_Catalog_2023,GIPR;ZC3H4;JAZF1,GIPR;ZC3H4;IGF2BP2;JAZF1,GIPR;ZC3H4;JAZF1,3,4,3
365,Polycystic Ovary Syndrome,0.0052133143061567685,4.908576623901404,25.80212682520637,GRN;CCND2;MTNR1B;APOE;HLA-DRB1,0.03116562141379197,DisGeNET,GRN;APOE;HLA-DRB1,CCND2;MTNR1B;HLA-DRB1,HLA-DRB1,3,3,1
367,Pancreatic carcinoma,0.0053803365325682,2.950103509544069,15.414303682834731,CDKN1C;CDKN2B;CCND2;MTNR1B;KCNQ1;CHST15;IGF2BP3;EML2;HLA-DRB1;NEUROG3,0.03158519384950702,DisGeNET,EML2;HLA-DRB1,CDKN1C;CDKN2B;CCND2;MTNR1B;KCNQ1;CHST15;IGF2BP3;EML2;HLA-DRB1;NEUROG3,EML2;HLA-DRB1,2,10,2
368,"Cockayne Syndrome, Type I",0.005384826815772965,19.818815331010452,103.53686305193918,APOE;HLA-DRB1,0.03158519384950702,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
369,Tardive Dyskinesia,0.005384826815772965,19.818815331010452,103.53686305193918,MTNR1B;APOE,0.03158519384950702,DisGeNET,APOE,MTNR1B,,1,1,0
370,Tumors of Adrenal Cortex,0.005384826815772965,19.818815331010452,103.53686305193918,CDKN1C;CCND2,0.03158519384950702,DisGeNET,,CDKN1C;CCND2,,0,2,0
371,C-reactive protein measurement,0.005384826815772965,19.818815331010452,103.53686305193918,TREM2;APOE,0.03158519384950702,DisGeNET,TREM2;APOE,,,2,0,0
372,Drug-induced tardive dyskinesia,0.005384826815772965,19.818815331010452,103.53686305193918,MTNR1B;APOE,0.03158519384950702,DisGeNET,APOE,MTNR1B,,1,1,0
366,Primary biliary cirrhosis,0.005354910558227355,6.1955029585798815,32.40087755860056,HLA-DRA;APOE;HLA-DRB1;HLA-DQB1,0.03158519384950702,DisGeNET,HLA-DRA;APOE;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB1,HLA-DRA;HLA-DRB1;HLA-DQB1,4,3,3
373,Fatigue,0.005412236933629751,6.176183734465943,32.23407600024988,HESX1;TREM2;BTNL2;HLA-DRB1,0.0316608605608046,DisGeNET,HESX1;TREM2;BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,4,2,2
374,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding),0.00543270588228766,9.107668711656443,47.499388099014006,BTNL2;HLA-DRB1;HLA-DQA1,0.03169562629719699,DisGeNET,BTNL2;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,BTNL2;HLA-DRB1;HLA-DQA1,3,3,3
375,Squamous cell carcinoma,0.005524088835887893,2.9378998993146905,15.273075006528131,CDKN1C;CDKN2B;GRN;CCND2;SLC22A18;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,0.03214283157308635,DisGeNET,GRN;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,CDKN1C;CDKN2B;CCND2;SLC22A18;HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,HLA-DRB1;HLA-DQA1;HLA-DQB1;JAZF1,6,8,4
376,Hippocampal sclerosis,0.005592617272449293,19.421463414634147,100.72568904417493,GRN;APOE,0.032455028958735,DisGeNET,GRN;APOE,,,2,0,0
128,Body Mass Index In Physically Active Individuals,0.004980226270684628,20.664244940321744,109.56761169296043,GIPR;ZC3H4,0.032467986772447846,GWAS_Catalog_2023,GIPR;ZC3H4,GIPR;ZC3H4,GIPR;ZC3H4,2,2,2
129,Predicted Developmental Stuttering,0.004980226270684628,20.664244940321744,109.56761169296043,TOX2;JADE2,0.032467986772447846,GWAS_Catalog_2023,,TOX2;JADE2,,0,2,0
377,Cerebrovascular accident,0.005704033902612337,4.08491168333688,21.10502975411673,TSPAN15;CDKN2B;GIPR;KCNQ1;APOE;HLA-DRB1,0.03293240543308889,DisGeNET,GIPR;APOE;HLA-DRB1,TSPAN15;CDKN2B;GIPR;KCNQ1;HLA-DRB1,GIPR;HLA-DRB1,3,5,2
378,Malignant mesothelioma,0.005705063819297709,6.081338600976063,31.418634493354006,CDKN2B;CCND2;IDUA;IGF2BP3,0.03293240543308889,DisGeNET,IDUA,CDKN2B;CCND2;IGF2BP3,,1,3,0
132,Creatinine Levels,0.005185385420771686,6.254180602006689,32.90894237025274,GIPR;KCNQ1;APOE;HLA-DQA1,0.03303719044597719,GWAS_Catalog_2023,GIPR;APOE;HLA-DQA1,GIPR;KCNQ1;HLA-DQA1,GIPR;HLA-DQA1,3,3,2
131,Free Cholesterol To Total Lipids Ratio In Very Large VLDL,0.005180691162792406,20.232723577235774,106.48111760263689,CCND2;HLA-DQA1,0.03303719044597719,GWAS_Catalog_2023,HLA-DQA1,CCND2;HLA-DQA1,HLA-DQA1,1,2,1
130,Glucose Homeostasis Traits,0.005180691162792406,20.232723577235774,106.48111760263689,MTNR1B;KCNQ1,0.03303719044597719,GWAS_Catalog_2023,,MTNR1B;KCNQ1,,0,2,0
379,Ovarian Carcinoma,0.0057609720138773034,2.7859118385036497,14.365969680262822,CDKN1C;CDKN2B;GRN;CCND2;CHST15;IGF2BP3;IGF2BP2;APOE;HLA-DRB1;APPL1;JAZF1,0.033167390327916296,DisGeNET,GRN;APOE;HLA-DRB1;APPL1;JAZF1,CDKN1C;CDKN2B;CCND2;CHST15;IGF2BP3;IGF2BP2;HLA-DRB1;JAZF1,HLA-DRB1;JAZF1,5,8,2
136,Free Cholesterol Levels In IDL,0.005384826815772965,19.818815331010452,103.53686305193918,APOE;HLA-DQA1,0.03329881876518429,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
135,Free Cholesterol Levels In Large LDL,0.005384826815772965,19.818815331010452,103.53686305193918,APOE;HLA-DQA1,0.03329881876518429,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
133,Nonalcoholic Fatty Liver Disease (Imputed),0.005384826815772965,19.818815331010452,103.53686305193918,HLA-DQA1;JAZF1,0.03329881876518429,GWAS_Catalog_2023,HLA-DQA1;JAZF1,HLA-DQA1;JAZF1,HLA-DQA1;JAZF1,2,2,2
134,Body Mass Index (Joint Analysis Main Effects And Physical Activity Interaction),0.005384826815772965,19.818815331010452,103.53686305193918,GIPR;ZC3H4,0.03329881876518429,GWAS_Catalog_2023,GIPR;ZC3H4,GIPR;ZC3H4,GIPR;ZC3H4,2,2,2
380,Keloid,0.0058977548930665615,8.834375,45.34846822211778,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.03386552941229273,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
137,High Density Lipoprotein Cholesterol Levels,0.005562854595870916,4.107323682521572,21.323761883977756,CCND2;GIPR;ZC3H4;SLC22A18;APOE;HLA-DQA1,0.03414861835859445,GWAS_Catalog_2023,GIPR;ZC3H4;APOE;HLA-DQA1,CCND2;GIPR;ZC3H4;SLC22A18;HLA-DQA1,GIPR;ZC3H4;HLA-DQA1,4,5,3
138,Body Mass Index (Joint Analysis Main Effects And Smoking Interaction),0.005804046626383199,19.039693926351028,98.03919026153727,ZC3H4;QPCTL,0.035116569876174605,GWAS_Catalog_2023,ZC3H4;QPCTL,ZC3H4;QPCTL,ZC3H4;QPCTL,2,2,2
139,Triglyceride Levels In Medium HDL,0.005804046626383199,19.039693926351028,98.03919026153727,CCND2;APOE,0.035116569876174605,GWAS_Catalog_2023,APOE,CCND2,,1,1,0
381,Immunoglobulin A deficiency (disorder),0.006237758643052818,18.319374137137597,93.00992375609684,PLCG2;HLA-DQB1,0.03572385658567257,DisGeNET,PLCG2;HLA-DQB1,HLA-DQB1,HLA-DQB1,2,1,1
140,BMI (Adjusted For Smoking Behaviour),0.006019099019507137,18.672607879924954,95.46963998767033,ZC3H4;QPCTL,0.03615758768146787,GWAS_Catalog_2023,ZC3H4;QPCTL,ZC3H4;QPCTL,ZC3H4;QPCTL,2,2,2
141,Itch Intensity From Mosquito Bite,0.006237758643052818,18.319374137137597,93.00992375609684,HLA-DQA2;HLA-DQA1,0.036943345202869154,GWAS_Catalog_2023,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,2,2,2
142,Sphingomyelin Levels,0.006237758643052818,18.319374137137597,93.00992375609684,APOE;HLA-DQA1,0.036943345202869154,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
382,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",0.006581072009459029,5.8303976217019695,29.289338444116243,CDKN2B;GRN;CCND2;IGF2BP3,0.037532137753828784,DisGeNET,GRN,CDKN2B;CCND2;IGF2BP3,,1,3,0
383,Cerebrovascular Disorders,0.0065879050227847956,8.478,42.58092357205864,APOE;HLA-DRB1;HLA-DQB1,0.037532137753828784,DisGeNET,APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
384,Abnormality of epiphysis morphology,0.006685836582770361,17.651441241685145,88.39425081534023,IDUA;TREM2,0.03762409770270743,DisGeNET,IDUA;TREM2,,,2,0,0
385,Abnormality of the voice,0.006685836582770361,17.651441241685145,88.39425081534023,HESX1;IL17RD,0.03762409770270743,DisGeNET,HESX1;IL17RD,,,2,0,0
386,Atrophic,0.006685836582770361,17.651441241685145,88.39425081534023,GRN;APOE,0.03762409770270743,DisGeNET,GRN;APOE,,,2,0,0
387,Scleroderma,0.006690261186365941,8.42940340909091,42.2068857392452,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.03762409770270743,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
388,Myasthenia Gravis,0.006690261186365941,8.42940340909091,42.2068857392452,HLA-DRB1;HLA-DQA1;HLA-DQB1,0.03762409770270743,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,3,3
144,Cholesteryl Esters To Total Lipids Ratio In Very Large VLDL,0.006460009734687234,17.979223125564587,90.65348059020808,APOE;HLA-DQA1,0.03772825129772197,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
143,Cholesterol To Total Lipids Ratio In Very Large VLDL,0.006460009734687234,17.979223125564587,90.65348059020808,CCND2;HLA-DQA1,0.03772825129772197,GWAS_Catalog_2023,HLA-DQA1,CCND2;HLA-DQA1,HLA-DQA1,1,2,1
32,Cystic fibrosis,0.008572851807857029,158.36507936507937,753.6839332107746,HLA-DRA,0.03777412827837003,Jensen_DISEASES,HLA-DRA,HLA-DRA,HLA-DRA,1,1,1
390,Heart valve disease,0.006915223521981038,17.335365853658537,86.2266296466296,IDUA;APOE,0.03859083817125991,DisGeNET,IDUA;APOE,,,2,0,0
389,Silicosis,0.006915223521981038,17.335365853658537,86.2266296466296,HLA-DRB1;HLA-DQB1,0.03859083817125991,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
391,Inclusion Body Myositis (disorder),0.006915223521981038,17.335365853658537,86.2266296466296,APOE;HLA-DRB1,0.03859083817125991,DisGeNET,APOE;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
393,Retinal Diseases,0.006982452988834796,5.7289794725692165,28.440687848756774,IDUA;APOE;HLA-DRB1;HLA-DQB1,0.03876771608559167,DisGeNET,IDUA;APOE;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,4,2,2
392,"Liver Cirrhosis, Experimental",0.006971575421911125,3.9086180520142784,19.40986130363712,GRN;HLA-DRA;IGF2BP3;HLA-DRB1;HLA-DQA1;APPL1,0.03876771608559167,DisGeNET,GRN;HLA-DRA;HLA-DRB1;HLA-DQA1;APPL1,HLA-DRA;IGF2BP3;HLA-DRB1;HLA-DQA1,HLA-DRA;HLA-DRB1;HLA-DQA1,5,4,3
394,Forgetful,0.0071481549361583725,17.03038083012409,84.14542578402569,GRN;TREM2,0.03938705573408477,DisGeNET,GRN;TREM2,,,2,0,0
395,Alopecia Areata,0.0071481549361583725,17.03038083012409,84.14542578402569,HLA-DRB1;HLA-DQB1,0.03938705573408477,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
396,Nephrocalcinosis,0.0071481549361583725,17.03038083012409,84.14542578402569,CDKN1C;KCNQ1,0.03938705573408477,DisGeNET,,CDKN1C;KCNQ1,,0,2,0
145,Serum Metabolite Levels (CMS),0.006915223521981038,17.335365853658537,86.2266296466296,MTNR1B;APOE,0.039562605319633015,GWAS_Catalog_2023,APOE,MTNR1B,,1,1,0
146,Triglycerides To Total Lipids Ratio In Small VLDL,0.006915223521981038,17.335365853658537,86.2266296466296,GIPR;HLA-DQA1,0.039562605319633015,GWAS_Catalog_2023,GIPR;HLA-DQA1,GIPR;HLA-DQA1,GIPR;HLA-DQA1,2,2,2
147,Waist Circumference Adjusted For BMI In Active Individuals,0.006915223521981038,17.335365853658537,86.2266296466296,KCNQ1;JAZF1,0.039562605319633015,GWAS_Catalog_2023,JAZF1,KCNQ1;JAZF1,JAZF1,1,2,1
397,Proteinuria,0.007216301156473271,8.194475138121547,40.41033927851615,APOE;HLA-DRB1;HLA-DQA1,0.03966239073910498,DisGeNET,APOE;HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,3,2,2
34,non-Hodgkin lymphoma,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQB1,0.03972056543117914,Jensen_DISEASES,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
33,Hemolytic anemia,0.010491791832734732,13.858536585365854,63.1555971026974,HLA-DRA;IL17RD,0.03972056543117914,Jensen_DISEASES,HLA-DRA;IL17RD,HLA-DRA,HLA-DRA,2,1,1
36,Acute urate nephropathy,0.010704833236771683,118.76785714285714,538.8568862241955,LRRC16A,0.03972056543117914,Jensen_DISEASES,,LRRC16A,,0,1,0
37,Agraphia,0.010704833236771683,118.76785714285714,538.8568862241955,GRN,0.03972056543117914,Jensen_DISEASES,GRN,,,1,0,0
38,Tic disorder,0.010704833236771683,118.76785714285714,538.8568862241955,PICALM,0.03972056543117914,Jensen_DISEASES,PICALM,,,1,0,0
35,Echolalia,0.010704833236771683,118.76785714285714,538.8568862241955,GRN,0.03972056543117914,Jensen_DISEASES,GRN,,,1,0,0
218,Lymphoma,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQB2,0.03973626442293962,GWAS_Catalog_2023,HLA-DQB2,HLA-DQB2,HLA-DQB2,1,1,1
213,Alkenylphosphatidylethanolamine (P-18:0/20:5) Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
214,Lamb Liking,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
212,Longevity (Age >90Th Survival Percentile),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
216,Killer Cell Immunoglobulin-Like Receptor 2DL5A Levels (KIR2DL5A.8000.17.3),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
217,Neutrophil Collagenase Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
219,Apolipoprotein E Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
226,Serum Levels Of Protein CXCL2;CXCL3,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
221,Apolipoprotein M Levels,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQB1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
222,"Sphingomyelin (D18:1/20:0, D16:1/22:0) Levels",0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
223,"Sphingomyelin (D18:1/22:1, D18:2/22:0, D16:1/24:1) Levels",0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
224,X-16935 Levels,0.010704833236771683,118.76785714285714,538.8568862241955,ATP8B4,0.03973626442293962,GWAS_Catalog_2023,ATP8B4,,,1,0,0
225,Body Mass Index (SNP X SNP Interaction),0.010704833236771683,118.76785714285714,538.8568862241955,GIPR,0.03973626442293962,GWAS_Catalog_2023,GIPR,GIPR,GIPR,1,1,1
227,IgG Glycosylation,0.010747428365657561,7.0525,31.969608584459383,PLCG2;IGF2BP3;HLA-DQB2,0.03973626442293962,GWAS_Catalog_2023,PLCG2;HLA-DQB2,IGF2BP3;HLA-DQB2,HLA-DQB2,2,2,1
228,Colorectal Cancer Or Advanced Adenoma,0.010772732804316568,13.662658880109928,61.90191516841718,TOX2;CCND2,0.03973626442293962,GWAS_Catalog_2023,,TOX2;CCND2,,0,2,0
211,Alkyldiacylglycerol (O-52:2) [NL-16:0] Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
220,Tumor Necrosis Factor Ligand Superfamily Member 18 Levels,0.010704833236771683,118.76785714285714,538.8568862241955,KCNQ1,0.03973626442293962,GWAS_Catalog_2023,,KCNQ1,,0,1,0
210,Alkenylphosphatidylethanolamine (P-18:1/20:3) (B) Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
215,Two-hour Glucose Challenge,0.010704833236771683,118.76785714285714,538.8568862241955,GIPR,0.03973626442293962,GWAS_Catalog_2023,GIPR,GIPR,GIPR,1,1,1
208,Cerebrospinal Fluid P-Tau Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
175,Fasting Total Lipids In Very Small VLDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
174,Fasting Free Cholesterol In Very Small VLDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
173,Fasting Phospholipid Levels In Very Small VLDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
172,Postprandial Phospholipid Levels In IDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
171,T Wave Morphology Restitution During Recovery From Exercise (MTAG),0.010704833236771683,118.76785714285714,538.8568862241955,KCNQ1,0.03973626442293962,GWAS_Catalog_2023,,KCNQ1,,0,1,0
170,T Wave Morphology Restitution During Recovery From Exercise,0.010704833236771683,118.76785714285714,538.8568862241955,KCNQ1,0.03973626442293962,GWAS_Catalog_2023,,KCNQ1,,0,1,0
169,IDP dMRI ProbtrackX ISOVF Slf R,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
168,IDP dMRI ProbtrackX ISOVF Ifo R,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
167,Serum Levels Of Protein LRP1B,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
209,Cholesteryl Ester (16:0) Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
164,Nonatopic Asthma Or Type 2 Diabetes,0.010704833236771683,118.76785714285714,538.8568862241955,JAZF1,0.03973626442293962,GWAS_Catalog_2023,JAZF1,JAZF1,JAZF1,1,1,1
163,Cervical Intraepithelial Neoplasia Grade 3 And Invasive Cervical Cancer,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
162,Psychosis Proneness (Hypomanic Personality Scale),0.010704833236771683,118.76785714285714,538.8568862241955,CDKN2B,0.03973626442293962,GWAS_Catalog_2023,,CDKN2B,,0,1,0
161,Total Triglycerides Levels,0.010214181683643169,14.060091905266878,64.45115426643397,CCND2;APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,CCND2,,1,1,0
160,Triglyceride Levels In LDL,0.009939917315218262,14.267575322812052,65.79059448688477,CCND2;APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,CCND2,,1,1,0
159,Eosinophil Percentage Of White Cells,0.009650291916518373,5.200212568088216,24.13297547008951,TOX2;SHARPIN;ALPK2;HLA-DQB1,0.03973626442293962,GWAS_Catalog_2023,SHARPIN;ALPK2;HLA-DQB1,TOX2;HLA-DQB1,HLA-DQB1,3,2,1
158,Alanine Aminotransferase Levels,0.009316289339638652,5.255739025372534,24.575787692946022,CCND2;ZC3H4;APOE;JAZF1,0.03973626442293962,GWAS_Catalog_2023,ZC3H4;APOE;JAZF1,CCND2;ZC3H4;JAZF1,ZC3H4;JAZF1,3,3,2
157,Triglyceride Levels In Medium LDL,0.008876618402253058,15.16234756097561,71.63200327629296,CCND2;APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,CCND2,,1,1,0
156,Triglycerides To Total Lipids Ratio In Medium VLDL,0.00861930890913937,15.40379403794038,73.22579161456777,APOE;HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
155,Free Cholesterol To Total Lipids Ratio In Medium LDL,0.00861930890913937,15.40379403794038,73.22579161456777,GIPR;APOE,0.03973626442293962,GWAS_Catalog_2023,GIPR;APOE,GIPR,GIPR,2,1,1
154,Free Cholesterol To Total Lipids Ratio In Large LDL,0.00861930890913937,15.40379403794038,73.22579161456777,GIPR;APOE,0.03973626442293962,GWAS_Catalog_2023,GIPR;APOE,GIPR,GIPR,2,1,1
153,Appendicular Lean Mass,0.008529120608179874,3.7369586453923804,17.80387629128009,CCND2;IDUA;ZC3H4;KCNQ1;HLA-DRB1;JAZF1,0.03973626442293962,GWAS_Catalog_2023,IDUA;ZC3H4;HLA-DRB1;JAZF1,CCND2;ZC3H4;KCNQ1;HLA-DRB1;JAZF1,ZC3H4;HLA-DRB1;JAZF1,4,5,3
152,Cholesterol To Total Lipids Ratio In Medium VLDL,0.008365435911281352,15.65302911093627,74.87856315796849,APOE;HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,APOE;HLA-DQA1,HLA-DQA1,HLA-DQA1,2,1,1
151,Total Bilirubin Levels,0.008223727852321358,7.802763157894737,37.45897214868451,CCND2;SLC22A18;JAZF1,0.03973626442293962,GWAS_Catalog_2023,JAZF1,CCND2;SLC22A18;JAZF1,JAZF1,1,3,1
150,Triglyceride Levels In Large LDL,0.008115014693377984,15.910435825669731,76.593462825792,CCND2;APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,CCND2,,1,1,0
149,Adult Body Size,0.00790722141739211,5.520710059171598,26.720119832722453,GIPR;ZC3H4;JADE2;APOE,0.03973626442293962,GWAS_Catalog_2023,GIPR;ZC3H4;APOE,GIPR;ZC3H4;JADE2,GIPR;ZC3H4,3,3,2
148,Waist Circumference Adjusted For BMI (Joint Analysis Main Effects And Physical Activity Interaction),0.0073846152576013385,16.735912531539107,82.14582442458652,KCNQ1;JAZF1,0.03973626442293962,GWAS_Catalog_2023,JAZF1,KCNQ1;JAZF1,JAZF1,1,2,1
176,Plasma Amyloid Beta Peptide Concentrations (ABx-42),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
177,Postprandial Triglycerides In LDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
166,Asthma And Major Depressive Disorder,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQB1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
179,Alpha-L-iduronidase Levels (IDUA.3169.70.2),0.010704833236771683,118.76785714285714,538.8568862241955,IDUA,0.03973626442293962,GWAS_Catalog_2023,IDUA,,,1,0,0
193,Hepatocellular Carcinoma,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
194,Lysoalkenylphosphatidylcholine (P-16:0) Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
195,Ceramide (D18:2/20:0) Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
196,Integral Membrane Protein 2B Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
197,Hippocampus Volume Change Rate X Age Interaction (2Df),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
178,Postprandial Phospholipid Levels In Medium VLDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
199,Lateral Ventricle Volume Change Rate X Age Interaction (2Df),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
200,Complement C1q Tumor Necrosis Factor-Related Protein 1 Levels,0.010704833236771683,118.76785714285714,538.8568862241955,GRN,0.03973626442293962,GWAS_Catalog_2023,GRN,,,1,0,0
201,Pyridoxine-5-phosphate Oxidase Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
202,Cervical Dysplasia,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
203,Surfeit Locus Protein 1 Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
204,Facial Morphology (Segment 9),0.010704833236771683,118.76785714285714,538.8568862241955,KCNQ1,0.03973626442293962,GWAS_Catalog_2023,,KCNQ1,,0,1,0
205,Parental Longevity (Mother'S Attained Age),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
206,Total Lysoalkenylphosphatidylcholine Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
207,Total Lysophosphatidylethanolamine Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
192,Lean Nonalcoholic Fatty Liver Disease,0.010704833236771683,118.76785714285714,538.8568862241955,BTNL2,0.03973626442293962,GWAS_Catalog_2023,BTNL2,BTNL2,BTNL2,1,1,1
191,Central Cerebrospinal Fluid Amyloid Beta 42 To 40 Ratio (Abnormal Vs Normal),0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
198,X-24870 Levels,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
185,Postprandial Triglycerides Levels In Very Large HDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
180,Fasting Triglycerides Levels In IDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
181,Fasting Free Cholesterol In IDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
182,Fasting Free Cholesterol In Medium VLDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
183,"Fasting Monounsaturated Fatty Acids (16:1, 18:1)",0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
184,Ubiquitin Carboxyl-Terminal Hydrolase 25 Levels (USP25.9215.117.3),0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQB1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
186,"N2,N5-diacetylornithine Levels In Elite Athletes",0.010704833236771683,118.76785714285714,538.8568862241955,JAZF1,0.03973626442293962,GWAS_Catalog_2023,JAZF1,JAZF1,JAZF1,1,1,1
187,Fasting Triglycerides Levels In Large LDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
188,Fasting Triglycerides In LDL,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
165,IDP dMRI TBSS ISOVF Anterior Corona Radiata L,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
189,Postprandial Very Small VLDL Particle Concentration,0.010704833236771683,118.76785714285714,538.8568862241955,APOE,0.03973626442293962,GWAS_Catalog_2023,APOE,,,1,0,0
190,Cutaneous Lupus Erythematosus,0.010704833236771683,118.76785714285714,538.8568862241955,HLA-DQA1,0.03973626442293962,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
398,"Lymphoma, Follicular",0.007258891401572193,5.663271939328277,27.894605422335975,CDKN1C;CDKN2B;HLA-DRB1;HLA-DQB1,0.03979623376439831,DisGeNET,HLA-DRB1;HLA-DQB1,CDKN1C;CDKN2B;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,4,2
39,Diabetes mellitus,0.011056989691574752,13.472222222222221,60.688218399017316,KCNQ1;APPL1,0.03997527042338564,Jensen_DISEASES,APPL1,KCNQ1,,1,1,0
399,MIXED LINEAGE LEUKEMIA,0.007324376147591877,8.149038461538462,40.0651330071299,GRN;IGF2BP3;PICALM,0.04005460840612901,DisGeNET,GRN;PICALM,IGF2BP3,,2,1,0
400,Factor V Leiden mutation,0.0073846152576013385,16.735912531539107,82.14582442458652,SLC22A18;APOE,0.04008266291563711,DisGeNET,APOE,SLC22A18,,1,1,0
402,Bullous pemphigoid,0.0073846152576013385,16.735912531539107,82.14582442458652,HLA-DRB1;HLA-DQB1,0.04008266291563711,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
401,Autoimmune thyroiditis,0.0073846152576013385,16.735912531539107,82.14582442458652,HLA-DRB1;HLA-DQB1,0.04008266291563711,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
403,Hashimoto Disease,0.00743341174066821,8.104098360655737,39.724428986169265,PLCG2;HLA-DRB1;HLA-DQB1,0.0402474055040646,DisGeNET,PLCG2;HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,3,2,2
257,Total Alkyldiacylglycerol Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
254,Tumor Protein P53-Inducible Protein 11 Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
242,Postprandial Triglycerides Levels In Small LDL,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
244,Postprandial Total Lipids In Very Small VLDL,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
245,Age Of Onset Of Parkinson Disease,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
246,Dehydrocholesteryl Ester (18:2) Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
247,Serum Total Cholesterol Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
248,Lysophosphatidylethanolamine (16:0) [Sn1] Levels,0.012832337737452553,95.00952380952381,413.84123997008294,HLA-DQB1,0.04057141367367518,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
249,Trihexosylcermide (D18:1/24:0) Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
250,Lysophosphatidylethanolamine (16:0) [Sn2] Levels,0.012832337737452553,95.00952380952381,413.84123997008294,HLA-DQB1,0.04057141367367518,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
251,Phosphatidylcholine (16:1 18:2) Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
252,Inactive Gamma-Glutamyltranspeptidase 2 Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
241,Fasting Triglycerides Levels In Very Large HDL,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
253,Putamen Volume Change Rate X Age Interaction (2Df),0.012832337737452553,95.00952380952381,413.84123997008294,APH1B,0.04057141367367518,GWAS_Catalog_2023,APH1B,,,1,0,0
256,Upper Eyelid Morphology,0.012832337737452553,95.00952380952381,413.84123997008294,PLCG2,0.04057141367367518,GWAS_Catalog_2023,PLCG2,,,1,0,0
258,Alkenylphosphatidylcholine (P-38:5) (B) Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
259,Longevity (Age >99Th Survival Percentile),0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
260,Alkenylphosphatidylcholine (P-18:0/22:5) Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
261,Alzheimer's Disease Biomarkers,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
262,Granulins Levels,0.012832337737452553,95.00952380952381,413.84123997008294,GRN,0.04057141367367518,GWAS_Catalog_2023,GRN,,,1,0,0
263,F-fatty Food Liking (Derived Food-Liking Factor),0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
264,Endothelial Monocyte-Activating Polypeptide 2 Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
265,Spread Type: Flora Pro-Active/Benecol (UKB Data Field 1428 2),0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
266,EGFR Mutation-Positive Lung Adenocarcinoma,0.012832337737452553,95.00952380952381,413.84123997008294,BTNL2,0.04057141367367518,GWAS_Catalog_2023,BTNL2,BTNL2,BTNL2,1,1,1
255,Transmembrane And Coiled-Coil Domains Protein 3 Levels,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
240,Postprandial Linoleic Acid (18:2),0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
243,Fasting Omega-3 Fatty Acids,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
238,Chronic Rhinosinusitis,0.012832337737452553,95.00952380952381,413.84123997008294,HLA-DQA1,0.04057141367367518,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
239,Postprandial Triglycerides Levels In IDL,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
230,Cervical Cancer,0.011635391796872908,13.106789716545814,58.37375928178501,HLA-DQA2;HLA-DQA1,0.04057141367367518,GWAS_Catalog_2023,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,HLA-DQA2;HLA-DQA1,2,2,2
231,Coffee Consumption,0.012831336034903537,12.432145090681676,54.152745328721444,ZC3H4;JADE2,0.04057141367367518,GWAS_Catalog_2023,ZC3H4,ZC3H4;JADE2,ZC3H4,1,2,1
232,Respiratory Diseases,0.012831336034903537,12.432145090681676,54.152745328721444,SHARPIN;JAZF1,0.04057141367367518,GWAS_Catalog_2023,SHARPIN;JAZF1,JAZF1,JAZF1,2,1,1
233,Psychosis Proneness (Hypomanic Personality Scale And Revised Physical Anhedonia Scale),0.012832337737452553,95.00952380952381,413.84123997008294,CDKN2B,0.04057141367367518,GWAS_Catalog_2023,,CDKN2B,,0,1,0
229,Gout,0.011056989691574752,13.472222222222221,60.688218399017316,KCNQ1;JAZF1,0.04057141367367518,GWAS_Catalog_2023,JAZF1,KCNQ1;JAZF1,JAZF1,1,2,1
235,T Wave Morphology Restitution During Exercise (MTAG),0.012832337737452553,95.00952380952381,413.84123997008294,KCNQ1,0.04057141367367518,GWAS_Catalog_2023,,KCNQ1,,0,1,0
236,Serum Levels Of Protein KLRC3,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
237,Cerebral Amyloid Angiopathy,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
234,Cerebral Microbleeds,0.012832337737452553,95.00952380952381,413.84123997008294,APOE,0.04057141367367518,GWAS_Catalog_2023,APOE,,,1,0,0
404,Obesity,0.007525400016102721,2.7967009924980197,13.674389269589854,GRN;CCND2;MTNR1B;GIPR;QPCTL;KCNQ1;IGF2BP2;APOE;HLA-DRB1;APPL1,0.04064461097805975,DisGeNET,GRN;GIPR;QPCTL;APOE;HLA-DRB1;APPL1,CCND2;MTNR1B;GIPR;QPCTL;KCNQ1;IGF2BP2;HLA-DRB1,GIPR;QPCTL;HLA-DRB1,6,7,3
405,Dyspnea,0.007654372956756307,8.015675675675675,39.05620471648322,TREM2;BTNL2;HLA-DRB1,0.04123911553491917,DisGeNET,TREM2;BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,3,2,2
267,High Light Scatter Reticulocyte Percentage Of Red Cells,0.013322932038499354,4.713604826546003,20.35461131501662,TSPAN15;ZC3H4;KCNQ1;APOE,0.04196474099017961,GWAS_Catalog_2023,ZC3H4;APOE,TSPAN15;ZC3H4;KCNQ1,ZC3H4,2,3,1
407,Osteomyelitis,0.007868060585360347,16.17642276422764,78.37385720842586,HLA-DRB1;HLA-DQB1,0.04203524841148281,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
408,Precursor cell lymphoblastic lymphoma,0.007868060585360347,16.17642276422764,78.37385720842586,CDKN2B;IDUA,0.04203524841148281,DisGeNET,IDUA,CDKN2B,,1,1,0
406,Xerostomia,0.007868060585360347,16.17642276422764,78.37385720842586,TREM2;HLA-DRB1,0.04203524841148281,DisGeNET,TREM2;HLA-DRB1,HLA-DRB1,HLA-DRB1,2,1,1
409,Dermatitis,0.007879201008385184,7.929144385026738,38.40503899102268,GRN;SHARPIN;HLA-DQA1,0.04203524841148281,DisGeNET,GRN;SHARPIN;HLA-DQA1,HLA-DQA1,HLA-DQA1,3,1,1
296,Multiple Sclerosis (OCB Status),0.014955374188168613,79.17063492063492,332.7292054829482,BTNL2,0.04206511602759132,GWAS_Catalog_2023,BTNL2,BTNL2,BTNL2,1,1,1
270,1-stearoyl-2-linoleoyl-GPE (18:0/18:2) Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
268,Liver Proton Density Fat Fraction,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
269,"Malignant Lymphoma (Non-Hodgkin Lymphoma, Multiple Myeloma, Or Hodgkin Lymphoma)",0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DQB1,0.04206511602759132,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
271,Autoimmune Hepatitis Type-1,0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DQA1,0.04206511602759132,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
297,Beta-endorphin Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
273,Plasma Amyloid Beta Peptide Concentrations (ABx-40),0.014955374188168613,79.17063492063492,332.7292054829482,KCNQ1,0.04206511602759132,GWAS_Catalog_2023,,KCNQ1,,0,1,0
299,Endoplasmic Reticulum Resident Protein 29 Levels,0.014955374188168613,79.17063492063492,332.7292054829482,BTNL2,0.04206511602759132,GWAS_Catalog_2023,BTNL2,BTNL2,BTNL2,1,1,1
298,F-fruit Liking (Derived Food-Liking Factor),0.014955374188168613,79.17063492063492,332.7292054829482,SNRPD2,0.04206511602759132,GWAS_Catalog_2023,SNRPD2,SNRPD2,SNRPD2,1,1,1
272,4-Hydroxyglutamate Levels In Elite Athletes,0.014955374188168613,79.17063492063492,332.7292054829482,APPL1,0.04206511602759132,GWAS_Catalog_2023,APPL1,,,1,0,0
295,Immunoglobulin A,0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DQA1,0.04206511602759132,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
294,Liver Liking,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
293,F-savour/caloric Food Liking (Derived Food-Liking Factor),0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
292,Cerebrospinal Fluid p-Tau181p:AB1-42 Ratio,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
291,Alkenylphosphatidylcholine (P-17:0/20:4) (B) Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
289,Total Cholesteryl Ester Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
288,Alkyldiacylglycerol (O-50:1) [NL-16:0] Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
287,Asthma (Time To Onset),0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DQA1,0.04206511602759132,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
286,Chronic Widespread Musculoskeletal Pain,0.014955374188168613,79.17063492063492,332.7292054829482,PLCG2,0.04206511602759132,GWAS_Catalog_2023,PLCG2,,,1,0,0
285,tRNA (guanine-N(7)-)-methyltransferase Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
290,Alkenylphosphatidylcholine (P-17:0/20:4) (A) Levels,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
277,Fasting Triglycerides Levels In Small LDL,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
279,Homoarginine Levels In Elite Athletes,0.014955374188168613,79.17063492063492,332.7292054829482,KCNQ1,0.04206511602759132,GWAS_Catalog_2023,,KCNQ1,,0,1,0
280,Lipoprotein(a) Levels Adjusted For Apolipoprotein(A) Isoforms,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
281,Ceramide Levels (C24:0),0.014955374188168613,79.17063492063492,332.7292054829482,PLCG2,0.04206511602759132,GWAS_Catalog_2023,PLCG2,,,1,0,0
284,Vigorous Physical Activity,0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
282,Medication Use (Antihistamines For Systemic Use),0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DQA1,0.04206511602759132,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
278,Response To Taxane Treatment (Placlitaxel),0.014955374188168613,79.17063492063492,332.7292054829482,TSPAN15,0.04206511602759132,GWAS_Catalog_2023,,TSPAN15,,0,1,0
276,Antineutrophil Cytoplasmic Antibody-Associated Vasculitis,0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DQA1,0.04206511602759132,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
275,Alcohol-associated Liver Disease In Heavy Drinkers,0.014955374188168613,79.17063492063492,332.7292054829482,JAZF1,0.04206511602759132,GWAS_Catalog_2023,JAZF1,JAZF1,JAZF1,1,1,1
274,Fasting Linoleic Acid (18:2),0.014955374188168613,79.17063492063492,332.7292054829482,APOE,0.04206511602759132,GWAS_Catalog_2023,APOE,,,1,0,0
283,Pancreatic Beta-Cell Glucose Sensitivity,0.014955374188168613,79.17063492063492,332.7292054829482,GIPR,0.04206511602759132,GWAS_Catalog_2023,GIPR,GIPR,GIPR,1,1,1
410,Platelet Count measurement,0.00799307005063061,7.88656914893617,38.085664813269844,IGF2BP2;APOE;PICALM,0.042538728903599984,DisGeNET,APOE;PICALM,IGF2BP2,,2,1,0
411,Idiopathic hypogonadotropic hypogonadism,0.008115014693377984,15.910435825669731,76.593462825792,HESX1;IL17RD,0.04308263275170501,DisGeNET,HESX1;IL17RD,,,2,0,0
300,Late-onset Alzheimer's Disease,0.015376516399398747,11.271128757799206,47.055991472096665,APH1B;APOE,0.04310550097298115,GWAS_Catalog_2023,APH1B;APOE,,,2,0,0
412,Hepatomegaly,0.008283418055481084,5.44451393231881,26.098275286715687,CDKN1C;IDUA;KCNQ1;APOE,0.04386994708024205,DisGeNET,IDUA;APOE,CDKN1C;KCNQ1,,2,2,0
413,Eclampsia,0.008340520412797967,7.76151832460733,37.15151385755788,CDKN1C;APOE;HLA-DRB1,0.04406541293153792,DisGeNET,APOE;HLA-DRB1,CDKN1C;HLA-DRB1,HLA-DRB1,2,2,1
301,Mean Reticulocyte Volume,0.015857989292081355,4.466346153846154,18.508904029156497,GIPR;IDUA;IGF2BP2;APOE,0.04430753818817416,GWAS_Catalog_2023,GIPR;IDUA;APOE,GIPR;IGF2BP2,GIPR,3,2,1
10,neoplasm of lung,0.029692279563515972,36.527472527472526,128.46230708138887,SLC22A18,0.04453841934527396,ClinVar_2019,,SLC22A18,,0,1,0
9,hypogonadotropic hypogonadism 7 with or without anosmia,0.029692279563515972,36.527472527472526,128.46230708138887,IL17RD,0.04453841934527396,ClinVar_2019,IL17RD,,,1,0,0
8,lung cancer,0.029692279563515972,36.527472527472526,128.46230708138887,SLC22A18,0.04453841934527396,ClinVar_2019,,SLC22A18,,0,1,0
7,age-related macular degeneration,0.027600267431624026,39.573412698412696,142.06577419675818,APOE,0.04453841934527396,ClinVar_2019,APOE,,,1,0,0
6,romano-ward syndrome,0.02340301917551725,47.49285714285714,178.33046577189359,KCNQ1,0.04453841934527396,ClinVar_2019,,KCNQ1,,0,1,0
4,hyperlipoproteinemia,0.017073951550447674,67.85714285714286,276.1922295799092,APOE,0.04453841934527396,ClinVar_2019,APOE,,,1,0,0
3,atrial fibrillation,0.012832337737452553,95.00952380952381,413.84123997008294,KCNQ1,0.04453841934527396,ClinVar_2019,,KCNQ1,,0,1,0
5,alzheimer's disease,0.0212977650246516,52.77248677248677,203.12938317607103,APOE,0.04453841934527396,ClinVar_2019,APOE,,,1,0,0
414,Stomach Neoplasms,0.008481404590747303,3.741662048055293,17.84727600336238,CDKN2B;CCND2;PLCG2;IGF2BP3;APOE;HLA-DQB1,0.04470150921983241,DisGeNET,PLCG2;APOE;HLA-DQB1,CDKN2B;CCND2;IGF2BP3;HLA-DQB1,HLA-DQB1,3,4,1
415,Hyperinsulinism,0.008592737958684057,5.385027840791916,25.615704287927098,CDKN1C;KCNQ1;APOE;HLA-DRB1,0.04507056304290532,DisGeNET,APOE;HLA-DRB1,CDKN1C;KCNQ1;HLA-DRB1,HLA-DRB1,2,3,1
416,Drug-Induced Liver Disease,0.008592737958684057,5.385027840791916,25.615704287927098,APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.04507056304290532,DisGeNET,APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,4,3,3
417,Limitation of joint mobility,0.00861930890913937,15.40379403794038,73.22579161456777,IDUA;TREM2,0.04510151568283479,DisGeNET,IDUA;TREM2,,,2,0,0
419,Cervix carcinoma,0.008676958012418379,3.3397338595426027,15.853998074408102,CDKN2B;GRN;SHARPIN;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.04518644960166325,DisGeNET,GRN;SHARPIN;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,CDKN2B;HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,6,5,4
418,Hepatitis B,0.008673436953429745,3.7229161935044286,17.674507949234567,CDKN2B;CCND2;APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2,0.04518644960166325,DisGeNET,APOE;HLA-DQA2;HLA-DRB1;HLA-DQB2,CDKN2B;CCND2;HLA-DQA2;HLA-DRB1;HLA-DQB2,HLA-DQA2;HLA-DRB1;HLA-DQB2,4,5,3
40,Sporotrichosis,0.012832337737452553,95.00952380952381,413.84123997008294,BTNL2,0.04523399052452025,Jensen_DISEASES,BTNL2,BTNL2,BTNL2,1,1,1
308,PH And SEC7 Domain-Containing Protein 1 Levels,0.017073951550447674,67.85714285714286,276.1922295799092,APOE,0.04602305530104646,GWAS_Catalog_2023,APOE,,,1,0,0
309,PEG-asparaginase Hypersensitivity Without Enzyme Activity In Childhood Acute Lymphoblastic Leukaemia,0.017073951550447674,67.85714285714286,276.1922295799092,HLA-DQA1,0.04602305530104646,GWAS_Catalog_2023,HLA-DQA1,HLA-DQA1,HLA-DQA1,1,1,1
310,Alkenylphosphatidylethanolamine (P-18:1/20:3) (A) Levels,0.017073951550447674,67.85714285714286,276.1922295799092,APOE,0.04602305530104646,GWAS_Catalog_2023,APOE,,,1,0,0
311,Alkenylphosphatidylcholine (P-18:0/20:4) Levels,0.017073951550447674,67.85714285714286,276.1922295799092,APOE,0.04602305530104646,GWAS_Catalog_2023,APOE,,,1,0,0
312,QT Interval (Drug Interaction),0.017073951550447674,67.85714285714286,276.1922295799092,CCND2,0.04602305530104646,GWAS_Catalog_2023,,CCND2,,0,1,0
305,Lamb Consumption,0.017073951550447674,67.85714285714286,276.1922295799092,APOE,0.04602305530104646,GWAS_Catalog_2023,APOE,,,1,0,0
304,Infant Head Circumference (MTAG),0.017073951550447674,67.85714285714286,276.1922295799092,IGF2BP3,0.04602305530104646,GWAS_Catalog_2023,,IGF2BP3,,0,1,0
307,Oral Cavity Cancer,0.017073951550447674,67.85714285714286,276.1922295799092,HLA-DQB1,0.04602305530104646,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
306,Cis-4-decenoylcarnitine (C10:1) Levels In Elite Athletes,0.017073951550447674,67.85714285714286,276.1922295799092,KCNQ1,0.04602305530104646,GWAS_Catalog_2023,,KCNQ1,,0,1,0
302,Cancer (Pleiotropy),0.017068397821674058,10.649155722326453,43.34767169794486,HLA-DQB1;JAZF1,0.04602305530104646,GWAS_Catalog_2023,HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,HLA-DQB1;JAZF1,2,2,2
303,Relative Carbohydrate Intake,0.017073951550447674,67.85714285714286,276.1922295799092,APOE,0.04602305530104646,GWAS_Catalog_2023,APOE,,,1,0,0
313,C-reactive Protein Levels,0.01729393173749476,4.347157190635452,17.638153870896787,TREM2;IGF2BP3;APOE;JAZF1,0.0464670817611281,GWAS_Catalog_2023,TREM2;APOE;JAZF1,IGF2BP3;JAZF1,JAZF1,3,2,1
314,Cigarettes Smoked Per Day (MTAG),0.017415911980779488,10.53287380699894,42.66204670923194,JADE2;APOE,0.04664580247081385,GWAS_Catalog_2023,APOE,JADE2,,1,1,0
421,Skin blisters,0.009137349155552274,14.928330206378988,70.09425716368078,HLA-DRB1;HLA-DQB1,0.046802102951678554,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
422,Toxic Epidermal Necrolysis,0.009137349155552274,14.928330206378988,70.09425716368078,HLA-DRB1;HLA-DQB1,0.046802102951678554,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
423,Abnormal blistering of the skin,0.009137349155552274,14.928330206378988,70.09425716368078,HLA-DRB1;HLA-DQB1,0.046802102951678554,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
424,Idiopathic Inflammatory Myopathies,0.009137349155552274,14.928330206378988,70.09425716368078,HLA-DRB1;HLA-DQA1,0.046802102951678554,DisGeNET,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,HLA-DRB1;HLA-DQA1,2,2,2
425,Joint swelling,0.009137349155552274,14.928330206378988,70.09425716368078,BTNL2;HLA-DRB1,0.046802102951678554,DisGeNET,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,BTNL2;HLA-DRB1,2,2,2
426,Arteriopathic disease,0.009137349155552274,14.928330206378988,70.09425716368078,CDKN2B;APOE,0.046802102951678554,DisGeNET,APOE,CDKN2B,,1,1,0
420,Gastric Adenocarcinoma,0.009070828253138711,5.298153034300792,24.915580305818118,IGF2BP3;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.046802102951678554,DisGeNET,HLA-DRB1;HLA-DQA1;HLA-DQB1,IGF2BP3;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,3,4,3
427,Chronic Lymphocytic Leukemia,0.00931208487055865,3.292103424178896,15.395331622973984,CDKN2B;CCND2;PLCG2;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.04749566200722322,DisGeNET,PLCG2;APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,CDKN2B;CCND2;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,5,5,3
428,"Hepatitis C, Chronic",0.009316289339638652,5.255739025372534,24.575787692946022,APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,0.04749566200722322,DisGeNET,APOE;HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQA1;HLA-DQB1,4,3,3
429,Skin bullae,0.009401485980373181,14.70140428677014,68.60980018036983,HLA-DRB1;HLA-DQB1,0.047698630751454724,DisGeNET,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,HLA-DRB1;HLA-DQB1,2,2,2
430,Human papilloma virus infection,0.009401485980373181,14.70140428677014,68.60980018036983,CDKN2B;HLA-DRB1,0.047698630751454724,DisGeNET,HLA-DRB1,CDKN2B;HLA-DRB1,HLA-DRB1,1,2,1
431,Glioblastoma Multiforme,0.009421681876203935,3.654194288628251,17.04587234362587,CDKN2B;GRN;SLC22A18;IGF2BP3;IGF2BP2;HLA-DRB1,0.047698630751454724,DisGeNET,GRN;HLA-DRB1,CDKN2B;SLC22A18;IGF2BP3;IGF2BP2;HLA-DRB1,HLA-DRB1,2,5,1
432,"Cardiomyopathy, Familial Idiopathic",0.00948232679497518,5.227831196581197,24.352939635811737,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,0.047894530246842225,DisGeNET,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQA1;HLA-DQB1,4,4,4
42,Psoriatic arthritis,0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DRB1,0.04792517637572215,Jensen_DISEASES,HLA-DRB1,HLA-DRB1,HLA-DRB1,1,1,1
43,Graves' disease,0.014955374188168613,79.17063492063492,332.7292054829482,HLA-DRB1,0.04792517637572215,Jensen_DISEASES,HLA-DRB1,HLA-DRB1,HLA-DRB1,1,1,1
44,Panhypopituitarism,0.014955374188168613,79.17063492063492,332.7292054829482,HESX1,0.04792517637572215,Jensen_DISEASES,HESX1,,,1,0,0
41,Endometrial stromal nodule,0.014955374188168613,79.17063492063492,332.7292054829482,JAZF1,0.04792517637572215,Jensen_DISEASES,JAZF1,JAZF1,JAZF1,1,1,1
434,Papilloma,0.009562545887048374,7.371641791044776,34.277406608692765,CDKN2B;APOE;HLA-DRB1,0.04807713162566717,DisGeNET,APOE;HLA-DRB1,CDKN2B;HLA-DRB1,HLA-DRB1,2,2,1
433,Osteogenesis Imperfecta,0.009562545887048374,7.371641791044776,34.277406608692765,CDKN1C;HESX1;TREM2,0.04807713162566717,DisGeNET,HESX1;TREM2,CDKN1C,,2,1,0
436,Cervical Intraepithelial Neoplasia,0.009690196471539413,7.334777227722772,34.00872572160105,HLA-DRB1;HLA-DQB2;HLA-DQB1,0.04849543280022706,DisGeNET,HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,HLA-DRB1;HLA-DQB2;HLA-DQB1,3,3,3
435,Kallmann Syndrome,0.009669013732444937,14.48125227520932,67.17605253596004,HESX1;IL17RD,0.04849543280022706,DisGeNET,HESX1;IL17RD,,,2,0,0
319,Galactonate Levels In Elite Athletes,0.01918807882344009,59.37202380952381,234.72528267100722,KCNQ1,0.04890052815307005,GWAS_Catalog_2023,,KCNQ1,,0,1,0
316,Rheumatic Heart Disease,0.01918807882344009,59.37202380952381,234.72528267100722,HLA-DQB1,0.04890052815307005,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
330,Posterior Urethral Valves,0.01918807882344009,59.37202380952381,234.72528267100722,ALPK2,0.04890052815307005,GWAS_Catalog_2023,ALPK2,,,1,0,0
329,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (Carboplatin),0.01918807882344009,59.37202380952381,234.72528267100722,PLCG2,0.04890052815307005,GWAS_Catalog_2023,PLCG2,,,1,0,0
328,Personality Dimensions,0.01918807882344009,59.37202380952381,234.72528267100722,IGF2BP3,0.04890052815307005,GWAS_Catalog_2023,,IGF2BP3,,0,1,0
327,Lewy Body Disease,0.01918807882344009,59.37202380952381,234.72528267100722,APOE,0.04890052815307005,GWAS_Catalog_2023,APOE,,,1,0,0
315,Nasopharyngeal Carcinoma,0.01918807882344009,59.37202380952381,234.72528267100722,CDKN2B,0.04890052815307005,GWAS_Catalog_2023,,CDKN2B,,0,1,0
325,Diacylglycerol (18:1 20:4) Levels,0.01918807882344009,59.37202380952381,234.72528267100722,APOE,0.04890052815307005,GWAS_Catalog_2023,APOE,,,1,0,0
326,Hip Circumference Variance,0.01918807882344009,59.37202380952381,234.72528267100722,GIPR,0.04890052815307005,GWAS_Catalog_2023,GIPR,GIPR,GIPR,1,1,1
323,GIP Levels In Response To Oral Glucose Tolerance Test (120 Minutes),0.01918807882344009,59.37202380952381,234.72528267100722,GIPR,0.04890052815307005,GWAS_Catalog_2023,GIPR,GIPR,GIPR,1,1,1
322,Acute Anterior Uveitis (With Or Without Ankylosing Spondylitis),0.01918807882344009,59.37202380952381,234.72528267100722,HLA-DQA2,0.04890052815307005,GWAS_Catalog_2023,HLA-DQA2,HLA-DQA2,HLA-DQA2,1,1,1
321,Infant Length,0.01918807882344009,59.37202380952381,234.72528267100722,IGF2BP3,0.04890052815307005,GWAS_Catalog_2023,,IGF2BP3,,0,1,0
320,Bullous Pemphigoid,0.01918807882344009,59.37202380952381,234.72528267100722,HLA-DQB1,0.04890052815307005,GWAS_Catalog_2023,HLA-DQB1,HLA-DQB1,HLA-DQB1,1,1,1
318,Parkinson's Disease (Age Of Onset),0.01918807882344009,59.37202380952381,234.72528267100722,APOE,0.04890052815307005,GWAS_Catalog_2023,APOE,,,1,0,0
317,Serum IgE Levels,0.01918807882344009,59.37202380952381,234.72528267100722,HLA-DRB1,0.04890052815307005,GWAS_Catalog_2023,HLA-DRB1,HLA-DRB1,HLA-DRB1,1,1,1
324,Central Cerebrospinal Fluid Amyloid Beta 42 To 40 Ratio,0.01918807882344009,59.37202380952381,234.72528267100722,APOE,0.04890052815307005,GWAS_Catalog_2023,APOE,,,1,0,0
437,"Glaucoma, Open-Angle",0.009939917315218262,14.267575322812052,65.79059448688477,CDKN2B;APOE,0.04963134915745137,DisGeNET,APOE,CDKN2B,,1,1,0
438,Ischemic stroke,0.00999204001426169,5.145825115055884,23.701498102715213,CDKN2B;KCNQ1;TREM2;APOE,0.049777697057349336,DisGeNET,TREM2;APOE,CDKN2B;KCNQ1,,2,2,0
